CONSOLIDATED SCHEDULE OF INVESTMENTS (Parenthetical) € in Thousands, £ in Thousands |
Sep. 30, 2026
USD ($)
firm
|
Sep. 30, 2026
EUR (€)
firm
|
Sep. 30, 2026
GBP (£)
firm
|
Dec. 31, 2025
USD ($)
firm
|
Dec. 31, 2025
EUR (€)
firm
|
Dec. 31, 2025
GBP (£)
firm
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
|
7.00%
|
|
7.00%
|
7.00%
|
6.75%
|
6.75%
|
6.75%
|
| Aggregate gross unrealized appreciation |
|
$ 120,100,000
|
|
|
|
$ 107,000,000.0
|
|
|
| Aggregate gross unrealized depreciation |
|
141,200,000
|
|
|
|
109,400,000
|
|
|
| Net unrealized appreciation (depreciation) over cost for U.S. federal income tax purposes |
|
21,100,000
|
|
|
|
2,400,000
|
|
|
| Aggregate cost of securities for U.S. federal income tax purposes (in billions) |
|
4,900,000,000
|
|
|
|
4,500,000,000
|
|
|
| Investment cost |
|
4,865,670,000
|
[1] |
|
|
4,467,968,000
|
|
|
| Investments, at fair value: |
|
$ 4,845,903,000
|
|
|
|
$ 4,466,647,000
|
|
|
| Contingent earn out payment receivable (as a percent) |
|
12.48%
|
|
12.48%
|
12.48%
|
12.48%
|
12.48%
|
12.48%
|
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total SeatGeek, Inc |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
$ 103,890,000
|
|
|
| Investment cost |
[2] |
|
|
|
|
105,935,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
105,935,000
|
|
|
| Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Total Gibraltar Acquisition, LLC |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
38,805,000
|
|
|
| Investment cost |
[2] |
|
|
|
|
38,255,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
$ 38,255,000
|
|
|
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Altimmune, Inc., Senior Secured, Maturity Date June 2029, Prime + 2.45%, Floor rate 9.70%, 6.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[4],[5],[6] |
|
|
|
|
2.45%
|
2.45%
|
2.45%
|
| Principal amount |
[3],[4],[5] |
|
|
|
|
$ 17,500,000
|
|
|
| Investment cost |
[2],[3],[4],[5] |
|
|
|
|
17,437,000
|
|
|
| Investments, at fair value: |
[3],[4],[5] |
|
|
|
|
$ 17,403,000
|
|
|
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Recover Together, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 9.90%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7] |
|
|
|
|
1.90%
|
1.90%
|
1.90%
|
| Principal amount |
[7] |
|
|
|
|
$ 46,500,000
|
|
|
| Investment cost |
[2],[7] |
|
|
|
|
48,117,000
|
|
|
| Investments, at fair value: |
[7] |
|
|
|
|
$ 47,862,000
|
|
|
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date August 2029, Prime + 1.05%, Floor rate 9.55%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6],[8] |
|
|
|
|
1.05%
|
1.05%
|
1.05%
|
| Principal amount |
[3],[8] |
|
|
|
|
$ 36,000,000
|
|
|
| Investment cost |
[2],[3],[8] |
|
|
|
|
35,899,000
|
|
|
| Investments, at fair value: |
[3],[8] |
|
|
|
|
$ 35,899,000
|
|
|
| Investment, Identifier [Axis]: Debt Investment Healthcare Technology & Digital Health and Modern Life, Inc., Senior Secured, Maturity Date February 2029, Prime + 2.75%, Floor rate 10.25%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[9] |
|
|
|
|
2.75%
|
2.75%
|
2.75%
|
| Principal amount |
[7],[9] |
|
|
|
|
$ 20,238,000
|
|
|
| Investment cost |
[2],[7],[9] |
|
|
|
|
20,281,000
|
|
|
| Investments, at fair value: |
[7],[9] |
|
|
|
|
$ 20,281,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[10],[11],[12] |
|
|
|
|
8.14%
|
8.14%
|
8.14%
|
| Principal amount |
[7],[10],[11],[12] |
|
|
|
|
$ 20,163,000
|
|
|
| Investment cost |
[2],[7],[10],[11],[12] |
|
|
|
|
19,919,000
|
|
|
| Investments, at fair value: |
[7],[10],[11],[12] |
|
|
|
|
$ 20,163,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and AlphaSense, Inc., Senior Secured, Maturity Date June 2029, 3-month SOFR + 6.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[13] |
|
|
|
|
6.25%
|
6.25%
|
6.25%
|
| Principal amount |
[10],[13] |
|
|
|
|
$ 20,000,000
|
|
|
| Investment cost |
[2],[10],[13] |
|
|
|
|
19,849,000
|
|
|
| Investments, at fair value: |
[10],[13] |
|
|
|
|
19,916,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Annex Cloud |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[10] |
|
|
|
|
10,683,000
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
10,684,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
$ 6,269,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Annex Cloud Senior Secured, Maturity Date June 2028, PIK Interest 3-month SOFR + 5.73%, Floor rate 6.73% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[12],[14] |
|
|
|
|
5.73%
|
5.73%
|
5.73%
|
| Principal amount |
[10],[12],[14] |
|
|
|
|
$ 1,716,000
|
|
|
| Investment cost |
[2],[10],[12],[14] |
|
|
|
|
1,717,000
|
|
|
| Investments, at fair value: |
[10],[12],[14] |
|
|
|
|
$ 687,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Annex Cloud, Senior Secured, Maturity Date December 2025, PIK Interest 3-month SOFR + 9.99%, Floor rate 10.99% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[12],[14],[15] |
|
|
|
|
9.99%
|
9.99%
|
9.99%
|
| Principal amount |
[10],[12],[14],[15] |
|
|
|
|
$ 3,325,000
|
|
|
| Investment cost |
[2],[10],[12],[14],[15] |
|
|
|
|
3,325,000
|
|
|
| Investments, at fair value: |
[10],[12],[14],[15] |
|
|
|
|
$ 3,325,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Annex Cloud, Senior Secured, Maturity Date June 2028, PIK Interest 3-month SOFR + 9.99%, Floor rate 10.99% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[10],[12],[14] |
|
|
|
|
9.99%
|
9.99%
|
9.99%
|
| Principal amount |
[7],[10],[12],[14] |
|
|
|
|
$ 5,642,000
|
|
|
| Investment cost |
[2],[7],[10],[12],[14] |
|
|
|
|
5,642,000
|
|
|
| Investments, at fair value: |
[7],[10],[12],[14] |
|
|
|
|
$ 2,257,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Babel Street, Senior Secured, December 2027, 3-month SOFR + 8.01%, Floor rate 9.01% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6],[10],[11],[12] |
|
|
|
|
8.01%
|
8.01%
|
8.01%
|
| Principal amount |
[3],[10],[11],[12] |
|
|
|
|
$ 65,937,000
|
|
|
| Investment cost |
[2],[3],[10],[11],[12] |
|
|
|
|
65,038,000
|
|
|
| Investments, at fair value: |
[3],[10],[11],[12] |
|
|
|
|
$ 64,738,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Behavox Limited, Senior Secured, Maturity Date September 2027, Prime - 0.55%, Floor rate 7.45%, PIK Interest 3.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[10],[11],[13],[16],[17] |
|
|
|
|
(0.55%)
|
(0.55%)
|
(0.55%)
|
| Principal amount |
[4],[10],[11],[13],[16],[17] |
|
|
|
|
$ 19,444,000
|
|
|
| Investment cost |
[2],[4],[10],[11],[13],[16],[17] |
|
|
|
|
19,596,000
|
|
|
| Investments, at fair value: |
[4],[10],[11],[13],[16],[17] |
|
|
|
|
$ 19,598,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Brain Corporation, Senior Secured, September 2028, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.50%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[10],[16] |
|
|
|
|
1.35%
|
1.35%
|
1.35%
|
| Principal amount |
[7],[10],[16] |
|
|
|
|
$ 32,830,000
|
|
|
| Investment cost |
[2],[7],[10],[16] |
|
|
|
|
32,865,000
|
|
|
| Investments, at fair value: |
[7],[10],[16] |
|
|
|
|
$ 33,410,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Carbyne, Inc., Senior Secured, February 2029, Prime + 3.50%, Floor rate 10.00%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11] |
|
|
|
|
3.50%
|
3.50%
|
3.50%
|
| Principal amount |
[10],[11] |
|
|
|
|
$ 7,450,000
|
|
|
| Investment cost |
[2],[10],[11] |
|
|
|
|
7,430,000
|
|
|
| Investments, at fair value: |
[10],[11] |
|
|
|
|
$ 7,711,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Ceros, Inc., Senior Secured, June 2027, 3-month SOFR + 8.99%, Floor rate 9.89% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[12] |
|
|
|
|
8.99%
|
8.99%
|
8.99%
|
| Principal amount |
[10],[12] |
|
|
|
|
$ 22,656,000
|
|
|
| Investment cost |
[2],[10],[12] |
|
|
|
|
22,543,000
|
|
|
| Investments, at fair value: |
[10],[12] |
|
|
|
|
$ 22,506,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Chainalysis, Inc., Senior Secured, June 2029, Prime + 2.95%, Floor rate 10.45% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10] |
|
|
|
|
2.95%
|
2.95%
|
2.95%
|
| Principal amount |
[10] |
|
|
|
|
$ 36,412,000
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
35,954,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
$ 36,143,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Dashlane, Inc., Senior Secured, December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 6.28% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[10],[13],[16],[18] |
|
|
|
|
3.05%
|
3.05%
|
3.05%
|
| Principal amount |
[7],[10],[13],[16],[18] |
|
|
|
|
$ 45,986,000
|
|
|
| Investment cost |
[2],[7],[10],[13],[16],[18] |
|
|
|
|
46,789,000
|
|
|
| Investments, at fair value: |
[7],[10],[13],[16],[18] |
|
|
|
|
$ 48,034,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Dispatch Technologies, Inc., Senior Secured, April 2028, 3-month SOFR + 7.86%, Floor rate 8.61% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[12] |
|
|
|
|
7.86%
|
7.86%
|
7.86%
|
| Principal amount |
[10],[11],[12] |
|
|
|
|
$ 8,751,000
|
|
|
| Investment cost |
[2],[10],[11],[12] |
|
|
|
|
8,634,000
|
|
|
| Investments, at fair value: |
[10],[11],[12] |
|
|
|
|
$ 8,524,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Distributed Creation Inc., Senior Secured, April 2029, Prime + 3.00%, Floor rate 10.25%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[13] |
|
|
|
|
3.00%
|
3.00%
|
3.00%
|
| Principal amount |
[10],[11],[13] |
|
|
|
|
$ 25,000,000
|
|
|
| Investment cost |
[2],[10],[11],[13] |
|
|
|
|
24,825,000
|
|
|
| Investments, at fair value: |
[10],[11],[13] |
|
|
|
|
$ 25,024,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and DocPlanner., Senior Secured, January 2030, Prime + 2.75%, Floor rate 9.75%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[10],[11],[17] |
|
|
|
|
2.75%
|
2.75%
|
2.75%
|
| Principal amount | € |
[4],[10],[11],[17] |
|
|
|
|
|
€ 68,200
|
|
| Investment cost |
[2],[4],[10],[11],[17] |
|
|
|
|
$ 69,857,000
|
|
|
| Investments, at fair value: |
[4],[10],[11],[17] |
|
|
|
|
$ 80,519,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Earnix, Inc., Senior Secured, June 2029, Prime - 1.15%, Floor rate 5.35%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[13],[16] |
|
|
|
|
(1.15%)
|
(1.15%)
|
(1.15%)
|
| Principal amount |
[10],[11],[13],[16] |
|
|
|
|
$ 20,049,000
|
|
|
| Investment cost |
[2],[10],[11],[13],[16] |
|
|
|
|
19,790,000
|
|
|
| Investments, at fair value: |
[10],[11],[13],[16] |
|
|
|
|
$ 20,126,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Funnel Holding AB (publ)., Senior Secured, October 2029, Prime + 0.60%, Floor rate 7.10%, Cap rate 8.60%, PIK Interest 3.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[10],[11],[16],[17],[18] |
|
|
|
|
0.60%
|
0.60%
|
0.60%
|
| Principal amount |
[4],[10],[11],[16],[17],[18] |
|
|
|
|
$ 18,433,000
|
|
|
| Investment cost |
[2],[4],[10],[11],[16],[17],[18] |
|
|
|
|
18,196,000
|
|
|
| Investments, at fair value: |
[4],[10],[11],[16],[17],[18] |
|
|
|
|
18,196,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Khoros, LLC, Senior Secured, May 2030, FIXED 10.00% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[10] |
|
|
|
|
11,704,000
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
11,704,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
$ 11,399,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and LinenMaster, LLC, Senior Secured, August 2029, 1-month SOFR + 8.28%, Floor rate 9.28% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[12] |
|
|
|
|
8.28%
|
8.28%
|
8.28%
|
| Principal amount |
[10],[11],[12] |
|
|
|
|
$ 11,500,000
|
|
|
| Investment cost |
[2],[10],[11],[12] |
|
|
|
|
11,179,000
|
|
|
| Investments, at fair value: |
[10],[11],[12] |
|
|
|
|
$ 11,096,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Loftware, Inc., Senior Secured, March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[12] |
|
|
|
|
7.88%
|
7.88%
|
7.88%
|
| Principal amount |
[10],[11],[12] |
|
|
|
|
$ 29,660,000
|
|
|
| Investment cost |
[2],[10],[11],[12] |
|
|
|
|
29,247,000
|
|
|
| Investments, at fair value: |
[10],[11],[12] |
|
|
|
|
$ 29,660,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and LogicSource., Senior Secured, July 2027, 3-month SOFR + 8.93%, Floor rate 9.93% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[12] |
|
|
|
|
8.93%
|
8.93%
|
8.93%
|
| Principal amount |
[10],[11],[12] |
|
|
|
|
$ 11,113,000
|
|
|
| Investment cost |
[2],[10],[11],[12] |
|
|
|
|
11,020,000
|
|
|
| Investments, at fair value: |
[10],[11],[12] |
|
|
|
|
$ 11,113,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Mango Technologies, Inc., Senior Secured, August 2030, Prime + 2.25%, Floor rate 8.25%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11] |
|
|
|
|
2.25%
|
2.25%
|
2.25%
|
| Principal amount |
[10],[11] |
|
|
|
|
$ 16,750,000
|
|
|
| Investment cost |
[2],[10],[11] |
|
|
|
|
16,528,000
|
|
|
| Investments, at fair value: |
[10],[11] |
|
|
|
|
$ 16,528,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Marigold Group, Inc., Senior Secured, April 2028, 6-month SOFR + 4.75%, Floor rate 5.75%, PIK Interest 5.25% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[10],[16],[18] |
|
|
|
|
4.75%
|
4.75%
|
4.75%
|
| Principal amount |
[7],[10],[16],[18] |
|
|
|
|
$ 44,555,000
|
|
|
| Investment cost |
[2],[7],[10],[16],[18] |
|
|
|
|
43,960,000
|
|
|
| Investments, at fair value: |
[7],[10],[16],[18] |
|
|
|
|
$ 40,736,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Omeda Holdings, LLC., Senior Secured, July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[12],[13] |
|
|
|
|
8.05%
|
8.05%
|
8.05%
|
| Principal amount |
[10],[11],[12],[13] |
|
|
|
|
$ 7,303,000
|
|
|
| Investment cost |
[2],[10],[11],[12],[13] |
|
|
|
|
7,207,000
|
|
|
| Investments, at fair value: |
[10],[11],[12],[13] |
|
|
|
|
$ 7,303,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Pindrop Security, Inc., Senior Secured, June 2029, Prime + 3.50%, Floor rate 10.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6],[10],[11] |
|
|
|
|
3.50%
|
3.50%
|
3.50%
|
| Principal amount |
[3],[10],[11] |
|
|
|
|
$ 31,000,000
|
|
|
| Investment cost |
[2],[3],[10],[11] |
|
|
|
|
30,759,000
|
|
|
| Investments, at fair value: |
[3],[10],[11] |
|
|
|
|
$ 31,338,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Proven Optics, LLC, Senior Secured, December 2030, 3-month SOFR + 7.30%, Floor rate 8.30% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[12] |
|
|
|
|
7.30%
|
7.30%
|
7.30%
|
| Principal amount |
[10],[11],[12] |
|
|
|
|
$ 15,000,000
|
|
|
| Investment cost |
[2],[10],[11],[12] |
|
|
|
|
14,726,000
|
|
|
| Investments, at fair value: |
[10],[11],[12] |
|
|
|
|
$ 14,726,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Remodel Health Holdco, LLC, Senior Secured, December 2028, Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[10] |
|
|
|
|
2.35%
|
2.35%
|
2.35%
|
| Principal amount |
[3],[5],[10] |
|
|
|
|
$ 25,000,000
|
|
|
| Investment cost |
[2],[3],[5],[10] |
|
|
|
|
25,126,000
|
|
|
| Investments, at fair value: |
[3],[5],[10] |
|
|
|
|
$ 25,334,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Reveleer, Senior Secured, February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[10],[16] |
|
|
|
|
0.65%
|
0.65%
|
0.65%
|
| Principal amount |
[3],[5],[10],[16] |
|
|
|
|
$ 50,052,000
|
|
|
| Investment cost |
[2],[3],[5],[10],[16] |
|
|
|
|
51,052,000
|
|
|
| Investments, at fair value: |
[3],[5],[10],[16] |
|
|
|
|
$ 50,938,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and ShadowDragon, LLC, Senior Secured, December 2026, 3-month SOFR + 8.79%, Floor rate 9.69% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[12] |
|
|
|
|
8.79%
|
8.79%
|
8.79%
|
| Principal amount |
[10],[11],[12] |
|
|
|
|
$ 6,000,000
|
|
|
| Investment cost |
[2],[10],[11],[12] |
|
|
|
|
5,958,000
|
|
|
| Investments, at fair value: |
[10],[11],[12] |
|
|
|
|
$ 5,958,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Simon Data, Inc., Senior Secured, March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 3.58% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[8],[10],[16] |
|
|
|
|
1.00%
|
1.00%
|
1.00%
|
| Principal amount |
[8],[10],[16] |
|
|
|
|
$ 11,350,000
|
|
|
| Investment cost |
[2],[8],[10],[16] |
|
|
|
|
11,560,000
|
|
|
| Investments, at fair value: |
[8],[10],[16] |
|
|
|
|
$ 11,343,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Sisense Ltd., Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[10],[16],[17] |
|
|
|
|
1.50%
|
1.50%
|
1.50%
|
| Principal amount |
[4],[10],[16],[17] |
|
|
|
|
$ 30,613,000
|
|
|
| Investment cost |
[2],[4],[10],[16],[17] |
|
|
|
|
31,624,000
|
|
|
| Investments, at fair value: |
[4],[10],[16],[17] |
|
|
|
|
$ 31,029,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Smartsheet Inc., Senior Secured, January 2031, 3-month SOFR + 6.50%, Floor rate 7.25% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11] |
|
|
|
|
6.50%
|
6.50%
|
6.50%
|
| Principal amount |
[10],[11] |
|
|
|
|
$ 46,785,000
|
|
|
| Investment cost |
[2],[10],[11] |
|
|
|
|
45,957,000
|
|
|
| Investments, at fair value: |
[10],[11] |
|
|
|
|
$ 46,204,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Snappt, Inc., Senior Secured, April 2029, Prime + 2.35%, Floor rate 8.85%, PIK Interest 1.00%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[10],[16] |
|
|
|
|
2.35%
|
2.35%
|
2.35%
|
| Principal amount |
[3],[5],[10],[16] |
|
|
|
|
$ 20,139,000
|
|
|
| Investment cost |
[2],[3],[5],[10],[16] |
|
|
|
|
20,071,000
|
|
|
| Investments, at fair value: |
[3],[5],[10],[16] |
|
|
|
|
$ 19,753,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Suzy, Inc., Senior Secured, August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[10],[16] |
|
|
|
|
1.75%
|
1.75%
|
1.75%
|
| Principal amount |
[3],[5],[10],[16] |
|
|
|
|
$ 24,827,000
|
|
|
| Investment cost |
[2],[3],[5],[10],[16] |
|
|
|
|
24,901,000
|
|
|
| Investments, at fair value: |
[3],[5],[10],[16] |
|
|
|
|
$ 24,378,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and TaxCalc, Senior Secured, November 2029, Daily SONIA + 8.17%, Floor rate 8.67% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[10],[11],[12],[17] |
|
|
|
|
8.17%
|
8.17%
|
8.17%
|
| Principal amount | £ |
[4],[10],[11],[12],[17] |
|
|
|
|
|
|
£ 8,250
|
| Investment cost |
[2],[4],[10],[11],[12],[17] |
|
|
|
|
$ 10,557,000
|
|
|
| Investments, at fair value: |
[4],[10],[11],[12],[17] |
|
|
|
|
10,897,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[10] |
|
|
|
|
115,161,000
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
114,849,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
$ 113,129,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Tipalti Solutions Ltd., Senior Secured, April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[16],[19] |
|
|
|
|
0.45%
|
0.45%
|
0.45%
|
| Principal amount |
[10],[16],[19] |
|
|
|
|
$ 72,488,000
|
|
|
| Investment cost |
[2],[10],[16],[19] |
|
|
|
|
72,141,000
|
|
|
| Investments, at fair value: |
[10],[16],[19] |
|
|
|
|
$ 70,507,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Tipalti Solutions Ltd., Senior Secured, April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[16],[19] |
|
|
|
|
0.45%
|
0.45%
|
0.45%
|
| Principal amount |
[10],[16],[19] |
|
|
|
|
$ 42,673,000
|
|
|
| Investment cost |
[2],[10],[16],[19] |
|
|
|
|
42,708,000
|
|
|
| Investments, at fair value: |
[10],[16],[19] |
|
|
|
|
$ 42,622,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Ushur, Inc. Senior Secured, June 2028, Prime + 2.20%, Floor rate 9.20%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[10] |
|
|
|
|
2.20%
|
2.20%
|
2.20%
|
| Principal amount |
[3],[5],[10] |
|
|
|
|
$ 14,400,000
|
|
|
| Investment cost |
[2],[3],[5],[10] |
|
|
|
|
14,191,000
|
|
|
| Investments, at fair value: |
[3],[5],[10] |
|
|
|
|
$ 14,106,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and Zappi, Inc. Senior Secured, December 2027, 3-month SOFR + 8.03%, Floor rate 9.03% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[7],[10],[11],[12],[17] |
|
|
|
|
8.03%
|
8.03%
|
8.03%
|
| Principal amount |
[4],[7],[10],[11],[12],[17] |
|
|
|
|
$ 12,600,000
|
|
|
| Investment cost |
[2],[4],[7],[10],[11],[12],[17] |
|
|
|
|
12,456,000
|
|
|
| Investments, at fair value: |
[4],[7],[10],[11],[12],[17] |
|
|
|
|
$ 12,614,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and ZeroEyes, Inc. Senior Secured, May 2030, Prime + 2.00%, Floor rate 9.50%, PIK Interest 2.00%, 1.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[10],[11],[16] |
|
|
|
|
2.00%
|
2.00%
|
2.00%
|
| Principal amount |
[3],[5],[10],[11],[16] |
|
|
|
|
$ 16,414,000
|
|
|
| Investment cost |
[2],[3],[5],[10],[11],[16] |
|
|
|
|
16,146,000
|
|
|
| Investments, at fair value: |
[3],[5],[10],[11],[16] |
|
|
|
|
16,218,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and iSpot.tv, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[10] |
|
|
|
|
42,421,000
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
42,265,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
$ 42,412,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and iSpot.tv, Inc., Senior Secured, January 2029, Prime + 1.40%, Floor rate 7.90%, PIK Interest 0.75%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[8],[10],[11],[16] |
|
|
|
|
1.40%
|
1.40%
|
1.40%
|
| Principal amount |
[8],[10],[11],[16] |
|
|
|
|
$ 39,139,000
|
|
|
| Investment cost |
[2],[8],[10],[11],[16] |
|
|
|
|
38,980,000
|
|
|
| Investments, at fair value: |
[8],[10],[11],[16] |
|
|
|
|
$ 39,147,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Application Software and iSpot.tv, Inc., Senior Secured, January 2029, Prime + 2.25%, Floor rate 8.75%, PIK Interest 1.00%, 5.70% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[16] |
|
|
|
|
2.25%
|
2.25%
|
2.25%
|
| Principal amount |
[10],[11],[16] |
|
|
|
|
$ 3,282,000
|
|
|
| Investment cost |
[2],[10],[11],[16] |
|
|
|
|
3,285,000
|
|
|
| Investments, at fair value: |
[10],[11],[16] |
|
|
|
|
$ 3,265,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Antheia, Inc., Senior Secured, Maturity Date August 2029, Prime + 2.85%, Floor rate 10.35%, 5.55% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6] |
|
|
|
|
2.85%
|
2.85%
|
2.85%
|
| Principal amount |
|
|
|
|
|
$ 21,250,000
|
|
|
| Investment cost |
[2] |
|
|
|
|
19,683,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
$ 19,683,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Communications and Networking and Aryaka Networks, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 6.73% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[8],[16],[18] |
|
|
|
|
1.80%
|
1.80%
|
1.80%
|
| Principal amount |
[8],[16],[18] |
|
|
|
|
$ 28,271,000
|
|
|
| Investment cost |
[2],[8],[16],[18] |
|
|
|
|
28,536,000
|
|
|
| Investments, at fair value: |
[8],[16],[18] |
|
|
|
|
$ 26,263,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Products Weee! Inc., Senior Secured, April 2028, Prime + 2.25%, Floor rate 9.75%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[11],[13] |
|
|
|
|
2.25%
|
2.25%
|
2.25%
|
| Principal amount |
[11],[13] |
|
|
|
|
$ 7,500,000
|
|
|
| Investment cost |
[2],[11],[13] |
|
|
|
|
7,472,000
|
|
|
| Investments, at fair value: |
[11],[13] |
|
|
|
|
$ 7,583,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc., Senior Secured, September 2029, Prime + 2.05%, Floor rate 8.55%, PIK Interest 1.00%, 4.70% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[16] |
|
|
|
|
2.05%
|
2.05%
|
2.05%
|
| Principal amount |
[16] |
|
|
|
|
$ 55,357,000
|
|
|
| Investment cost |
[2],[16] |
|
|
|
|
54,713,000
|
|
|
| Investments, at fair value: |
[16] |
|
|
|
|
$ 54,713,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD, Senior Secured, December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[16],[17] |
|
|
|
|
4.70%
|
4.70%
|
4.70%
|
| Principal amount | £ |
[4],[16],[17] |
|
|
|
|
|
|
£ 20,662
|
| Investment cost |
[2],[4],[16],[17] |
|
|
|
|
$ 28,533,000
|
|
|
| Investments, at fair value: |
[4],[16],[17] |
|
|
|
|
$ 27,960,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and GoEuro Travel GmbH, Senior Secured, November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[11],[17] |
|
|
|
|
3.45%
|
3.45%
|
3.45%
|
| Principal amount |
[4],[11],[17] |
|
|
|
|
$ 48,750,000
|
|
|
| Investment cost |
[2],[4],[11],[17] |
|
|
|
|
48,750,000
|
|
|
| Investments, at fair value: |
[4],[11],[17] |
|
|
|
|
49,137,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc., Convertible Debt, May 2028, PIK Interest 12.00% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[16],[20] |
|
|
|
|
28,901,000
|
|
|
| Investment cost |
[2],[16],[20] |
|
|
|
|
28,901,000
|
|
|
| Investments, at fair value: |
[16],[20] |
|
|
|
|
$ 30,986,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, October 2028, 1-month SOFR + 3.50%, Floor rate 4.50%, PIK Interest 3.25%, 6.42% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[16],[17] |
|
|
|
|
3.50%
|
3.50%
|
3.50%
|
| Principal amount |
[4],[16],[17] |
|
|
|
|
$ 14,270,000
|
|
|
| Investment cost |
[2],[4],[16],[17] |
|
|
|
|
14,839,000
|
|
|
| Investments, at fair value: |
[4],[16],[17] |
|
|
|
|
$ 14,082,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Nerdy Inc., Senior Secured, November 2029, Prime + 3.50%, Floor rate 10.75%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[11] |
|
|
|
|
3.50%
|
3.50%
|
3.50%
|
| Principal amount |
[11] |
|
|
|
|
$ 14,000,000
|
|
|
| Investment cost |
[2],[11] |
|
|
|
|
13,867,000
|
|
|
| Investments, at fair value: |
[11] |
|
|
|
|
$ 13,867,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Peek Travel Inc., Senior Secured, October 2028, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[11],[16] |
|
|
|
|
1.75%
|
1.75%
|
1.75%
|
| Principal amount |
[11],[16] |
|
|
|
|
$ 16,515,000
|
|
|
| Investment cost |
[2],[11],[16] |
|
|
|
|
16,280,000
|
|
|
| Investments, at fair value: |
[11],[16] |
|
|
|
|
$ 16,280,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd, Senior Secured, October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[7],[17] |
|
|
|
|
2.55%
|
2.55%
|
2.55%
|
| Principal amount |
[4],[7],[17] |
|
|
|
|
$ 3,035,000
|
|
|
| Investment cost |
[2],[4],[7],[17] |
|
|
|
|
3,073,000
|
|
|
| Investments, at fair value: |
[4],[7],[17] |
|
|
|
|
$ 3,073,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, December 2027, Prime + 4.40%, Floor rate 10.65%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6] |
|
|
|
|
4.40%
|
4.40%
|
4.40%
|
| Principal amount |
[3] |
|
|
|
|
$ 15,443,000
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
15,394,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
$ 15,389,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 9.50%, Floor rate 10.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6],[7],[16] |
|
|
|
|
9.50%
|
9.50%
|
9.50%
|
| Principal amount |
[3],[7],[16] |
|
|
|
|
$ 25,809,000
|
|
|
| Investment cost |
[2],[3],[7],[16] |
|
|
|
|
25,719,000
|
|
|
| Investments, at fair value: |
[3],[7],[16] |
|
|
|
|
$ 25,719,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC, Senior Secured, March 2028, 1-month SOFR + 8.28%, Floor rate 9.28% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[12] |
|
|
|
|
8.28%
|
8.28%
|
8.28%
|
| Principal amount |
[12] |
|
|
|
|
$ 36,126,000
|
|
|
| Investment cost |
[2],[12] |
|
|
|
|
35,850,000
|
|
|
| Investments, at fair value: |
[12] |
|
|
|
|
$ 35,546,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek Inc., Senior Secured, July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[8],[16],[19] |
|
|
|
|
2.50%
|
2.50%
|
2.50%
|
| Principal amount |
[8],[16],[19] |
|
|
|
|
$ 78,434,000
|
|
|
| Investment cost |
[2],[8],[16],[19] |
|
|
|
|
79,685,000
|
|
|
| Investments, at fair value: |
[8],[16],[19] |
|
|
|
|
$ 79,685,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek Inc., Senior Secured, May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[13],[16],[19] |
|
|
|
|
7.00%
|
7.00%
|
7.00%
|
| Principal amount |
[13],[16],[19] |
|
|
|
|
$ 25,456,000
|
|
|
| Investment cost |
[2],[13],[16],[19] |
|
|
|
|
26,250,000
|
|
|
| Investments, at fair value: |
[13],[16],[19] |
|
|
|
|
$ 26,250,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[16] |
|
|
|
|
2.75%
|
2.75%
|
2.75%
|
| Principal amount |
[7],[16] |
|
|
|
|
$ 6,705,000
|
|
|
| Investment cost |
[2],[7],[16] |
|
|
|
|
6,913,000
|
|
|
| Investments, at fair value: |
[7],[16] |
|
|
|
|
6,705,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date January 2027, FIXED 8.25% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[21] |
|
|
|
|
8,250,000
|
|
|
| Investment cost |
[2],[21] |
|
|
|
|
8,250,000
|
|
|
| Investments, at fair value: |
[21] |
|
|
|
|
$ 8,091,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc., Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[13],[16] |
|
|
|
|
2.45%
|
2.45%
|
2.45%
|
| Principal amount |
[13],[16] |
|
|
|
|
$ 21,238,000
|
|
|
| Investment cost |
[2],[13],[16] |
|
|
|
|
20,976,000
|
|
|
| Investments, at fair value: |
[13],[16] |
|
|
|
|
$ 21,663,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Akeyless Security Ltd. and Senior Secured and Maturity Date August 2028 and Prime + 4.00%, Floor rate 11.00%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[9],[10],[11],[17] |
|
|
|
|
4.00%
|
4.00%
|
4.00%
|
| Principal amount |
[4],[9],[10],[11],[17] |
|
|
|
|
$ 10,000,000
|
|
|
| Investment cost |
[2],[4],[9],[10],[11],[17] |
|
|
|
|
9,848,000
|
|
|
| Investments, at fair value: |
[4],[9],[10],[11],[17] |
|
|
|
|
$ 9,848,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Coronet Cyber Security Ltd. and Senior Secured and Maturity Date October 2028 and Prime - 2.95%, Floor rate 3.55%, PIK Interest 5.85% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[9],[10],[16] |
|
|
|
|
(2.95%)
|
(2.95%)
|
(2.95%)
|
| Principal amount |
[9],[10],[16] |
|
|
|
|
$ 9,115,000
|
|
|
| Investment cost |
[2],[9],[10],[16] |
|
|
|
|
8,999,000
|
|
|
| Investments, at fair value: |
[9],[10],[16] |
|
|
|
|
$ 8,759,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and DNSFilter, Inc. and Senior Secured and Maturity Date October 2028 and Prime + 2.15%, Floor rate 8.65%, PIK Interest 0.75%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[9],[10],[11],[16],[18] |
|
|
|
|
2.15%
|
2.15%
|
2.15%
|
| Principal amount |
[9],[10],[11],[16],[18] |
|
|
|
|
$ 5,009,000
|
|
|
| Investment cost |
[2],[9],[10],[11],[16],[18] |
|
|
|
|
4,968,000
|
|
|
| Investments, at fair value: |
[9],[10],[11],[16],[18] |
|
|
|
|
$ 4,968,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and LogRhythm, Inc. and Senior Secured and Maturity Date July 2029 and 3-month SOFR + 7.50%, Floor rate 8.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[9],[10] |
|
|
|
|
7.50%
|
7.50%
|
7.50%
|
| Principal amount |
[9],[10] |
|
|
|
|
$ 25,000,000
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
24,428,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
$ 23,977,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Morphisec Information Security 2014 Ltd. and Senior Secured and Maturity Date October 2027 and Prime + 3.45%, Floor rate 11.70%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[9],[10],[17] |
|
|
|
|
3.45%
|
3.45%
|
3.45%
|
| Principal amount |
[4],[9],[10],[17] |
|
|
|
|
$ 11,435,000
|
|
|
| Investment cost |
[2],[4],[9],[10],[17] |
|
|
|
|
11,574,000
|
|
|
| Investments, at fair value: |
[4],[9],[10],[17] |
|
|
|
|
$ 11,496,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Semperis Technologies Inc. and Senior Secured and Maturity Date April 2028 and Prime - 0.50%, Floor rate 8.00%, PIK Interest 3.85% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[9],[10],[16],[18] |
|
|
|
|
(0.50%)
|
(0.50%)
|
(0.50%)
|
| Principal amount |
[9],[10],[16],[18] |
|
|
|
|
$ 33,815,000
|
|
|
| Investment cost |
[2],[9],[10],[16],[18] |
|
|
|
|
33,363,000
|
|
|
| Investments, at fair value: |
[9],[10],[16],[18] |
|
|
|
|
$ 33,350,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Semperis Technologies Inc. and Senior Secured and Maturity Date April 2028 and Prime - 1.75%, Floor rate 6.75%, PIK Interest 3.25% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[9],[10],[13],[16],[18] |
|
|
|
|
(1.75%)
|
(1.75%)
|
(1.75%)
|
| Principal amount |
[9],[10],[13],[16],[18] |
|
|
|
|
$ 23,511,000
|
|
|
| Investment cost |
[2],[9],[10],[13],[16],[18] |
|
|
|
|
23,300,000
|
|
|
| Investments, at fair value: |
[9],[10],[13],[16],[18] |
|
|
|
|
$ 23,736,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Sumo Logic, Inc. and Senior Secured and Maturity Date May 2030 and 3-month SOFR + 6.50%, Floor rate 7.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[9],[10],[11] |
|
|
|
|
6.50%
|
6.50%
|
6.50%
|
| Principal amount |
[9],[10],[11] |
|
|
|
|
$ 23,000,000
|
|
|
| Investment cost |
[2],[9],[10],[11] |
|
|
|
|
22,591,000
|
|
|
| Investments, at fair value: |
[9],[10],[11] |
|
|
|
|
22,796,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Total Semperis Technologies Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[9] |
|
|
|
|
57,326,000
|
|
|
| Investment cost |
[2],[9] |
|
|
|
|
56,663,000
|
|
|
| Investments, at fair value: |
[9] |
|
|
|
|
$ 57,086,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Cybersecurity and Zimperium, Inc. and Senior Secured and Maturity Date May 2027 and 6-month SOFR + 8.31%, Floor rate 9.31% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[9],[10],[11],[12] |
|
|
|
|
8.31%
|
8.31%
|
8.31%
|
| Principal amount |
[9],[10],[11],[12] |
|
|
|
|
$ 17,771,000
|
|
|
| Investment cost |
[2],[9],[10],[11],[12] |
|
|
|
|
17,638,000
|
|
|
| Investments, at fair value: |
[9],[10],[11],[12] |
|
|
|
|
$ 17,619,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Defense Technologies and Saronic Technologies, Inc., Senior Secured, June 2030, Prime + 2.50%, Floor rate 9.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[11] |
|
|
|
|
2.50%
|
2.50%
|
2.50%
|
| Principal amount |
[3],[5],[11] |
|
|
|
|
$ 21,250,000
|
|
|
| Investment cost |
[2],[3],[5],[11] |
|
|
|
|
20,974,000
|
|
|
| Investments, at fair value: |
[3],[5],[11] |
|
|
|
|
$ 21,237,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Defense Technologies and Shield AI, Inc., Senior Secured, February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[8],[16],[19] |
|
|
|
|
0.85%
|
0.85%
|
0.85%
|
| Principal amount |
[8],[16],[19] |
|
|
|
|
$ 116,675,000
|
|
|
| Investment cost |
[2],[8],[16],[19] |
|
|
|
|
116,535,000
|
|
|
| Investments, at fair value: |
[8],[16],[19] |
|
|
|
|
116,843,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date July 2029, FIXED 11.95% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[21],[22] |
|
|
|
|
10,000,000
|
|
|
| Investment cost |
[2],[21],[22] |
|
|
|
|
9,843,000
|
|
|
| Investments, at fair value: |
[21],[22] |
|
|
|
|
9,843,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC, Unsecured, Maturity Date July 2029, FIXED 3.45%, PIK Interest 8.05% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[16],[21],[22] |
|
|
|
|
28,805,000
|
|
|
| Investment cost |
[2],[16],[21],[22] |
|
|
|
|
28,412,000
|
|
|
| Investments, at fair value: |
[16],[21],[22] |
|
|
|
|
$ 28,412,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc., Senior Secured, Maturity Date April 2026, Prime + 3.10%, Floor rate 11.10%, 8.90% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[13] |
|
|
|
|
3.10%
|
3.10%
|
3.10%
|
| Principal amount |
[13] |
|
|
|
|
$ 15,000,000
|
|
|
| Investment cost |
[2],[13] |
|
|
|
|
15,246,000
|
|
|
| Investments, at fair value: |
[13] |
|
|
|
|
$ 15,246,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alector, Inc., Senior Secured, Maturity Date December 2028, Prime + 1.05%, Floor rate 8.05%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[4],[5],[6],[11] |
|
|
|
|
1.05%
|
1.05%
|
1.05%
|
| Principal amount |
[3],[4],[5],[11] |
|
|
|
|
$ 7,000,000
|
|
|
| Investment cost |
[2],[3],[4],[5],[11] |
|
|
|
|
7,044,000
|
|
|
| Investments, at fair value: |
[3],[4],[5],[11] |
|
|
|
|
$ 7,055,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Arcus Biosciences, Inc., Senior Secured, Maturity Date September 2030, Prime - 0.05%, Floor rate 8.45%, PIK Interest 2.20%, 9.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[4],[5],[6],[11],[13],[16] |
|
|
|
|
(0.05%)
|
(0.05%)
|
(0.05%)
|
| Principal amount |
[3],[4],[5],[11],[13],[16] |
|
|
|
|
$ 75,704,000
|
|
|
| Investment cost |
[2],[3],[4],[5],[11],[13],[16] |
|
|
|
|
76,173,000
|
|
|
| Investments, at fair value: |
[3],[4],[5],[11],[13],[16] |
|
|
|
|
$ 79,788,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Beren Therapeutics P.B.C., Senior Secured, Maturity Date October 2029, Prime + 2.45%, Floor rate 9.95%, 5.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[5],[6] |
|
|
|
|
2.45%
|
2.45%
|
2.45%
|
| Principal amount |
[5] |
|
|
|
|
$ 8,625,000
|
|
|
| Investment cost |
[2],[5] |
|
|
|
|
8,471,000
|
|
|
| Investments, at fair value: |
[5] |
|
|
|
|
$ 8,471,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 3.00%, Floor rate 10.50%, PIK Interest 0.25%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[16] |
|
|
|
|
3.00%
|
3.00%
|
3.00%
|
| Principal amount |
[16] |
|
|
|
|
$ 53,633,000
|
|
|
| Investment cost |
[2],[16] |
|
|
|
|
54,463,000
|
|
|
| Investments, at fair value: |
[16] |
|
|
|
|
$ 55,720,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and COMPASS Pathways plc, Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[13],[16],[17] |
|
|
|
|
1.50%
|
1.50%
|
1.50%
|
| Principal amount |
[4],[13],[16],[17] |
|
|
|
|
$ 24,840,000
|
|
|
| Investment cost |
[2],[4],[13],[16],[17] |
|
|
|
|
25,464,000
|
|
|
| Investments, at fair value: |
[4],[13],[16],[17] |
|
|
|
|
$ 25,543,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc., Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7] |
|
|
|
|
5.70%
|
5.70%
|
5.70%
|
| Principal amount |
[7] |
|
|
|
|
$ 86,925,000
|
|
|
| Investment cost |
[2],[7] |
|
|
|
|
92,296,000
|
|
|
| Investments, at fair value: |
[7] |
|
|
|
|
$ 92,296,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Disc Medicine, Inc., Senior Secured, Maturity Date December 2029, Prime + 1.75%, Floor rate 8.25%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[4],[5],[6],[11] |
|
|
|
|
1.75%
|
1.75%
|
1.75%
|
| Principal amount |
[3],[4],[5],[11] |
|
|
|
|
$ 22,500,000
|
|
|
| Investment cost |
[2],[3],[4],[5],[11] |
|
|
|
|
22,659,000
|
|
|
| Investments, at fair value: |
[3],[4],[5],[11] |
|
|
|
|
$ 23,279,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Dyne Therapeutics, Inc., Senior Secured, Maturity Date July 2030, Prime + 2.45%, Floor rate 9.95%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[4],[5],[6] |
|
|
|
|
2.45%
|
2.45%
|
2.45%
|
| Principal amount |
[3],[4],[5] |
|
|
|
|
$ 100,000,000
|
|
|
| Investment cost |
[2],[3],[4],[5] |
|
|
|
|
99,389,000
|
|
|
| Investments, at fair value: |
[3],[4],[5] |
|
|
|
|
$ 101,148,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Genetix Biotherapeutics Inc. (p.k.a. bluebird bio, Inc.), Senior Secured, Maturity Date April 2029, Prime + 2.45%, Floor rate 9.45%, 6.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[16] |
|
|
|
|
2.45%
|
2.45%
|
2.45%
|
| Principal amount |
[16] |
|
|
|
|
$ 67,116,000
|
|
|
| Investment cost |
[2],[16] |
|
|
|
|
66,811,000
|
|
|
| Investments, at fair value: |
[16] |
|
|
|
|
$ 66,664,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, Maturity Date September 2030, Prime + 1.95%, Floor rate 9.45%, PIK Interest 1.00%, 6.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6],[16] |
|
|
|
|
1.95%
|
1.95%
|
1.95%
|
| Principal amount |
[3],[16] |
|
|
|
|
$ 80,368,000
|
|
|
| Investment cost |
[2],[3],[16] |
|
|
|
|
79,892,000
|
|
|
| Investments, at fair value: |
[3],[16] |
|
|
|
|
$ 79,892,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[4],[6] |
|
|
|
|
2.40%
|
2.40%
|
2.40%
|
| Principal amount |
[3],[4] |
|
|
|
|
$ 5,500,000
|
|
|
| Investment cost |
[2],[3],[4] |
|
|
|
|
5,712,000
|
|
|
| Investments, at fair value: |
[3],[4] |
|
|
|
|
$ 5,833,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and MoonLake Immunotherapeutics, Senior Secured, Maturity Date April 2030, Prime + 1.45%, Floor rate 8.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[17] |
|
|
|
|
1.45%
|
1.45%
|
1.45%
|
| Principal amount |
[4],[17] |
|
|
|
|
$ 34,500,000
|
|
|
| Investment cost |
[2],[4],[17] |
|
|
|
|
34,479,000
|
|
|
| Investments, at fair value: |
[4],[17] |
|
|
|
|
34,246,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and NorthSea Therapeutics, Convertible Debt, Maturity Date December 2026, FIXED 6.00% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[4],[17],[20] |
|
|
|
|
373,000
|
|
|
| Investment cost |
[2],[4],[17],[20] |
|
|
|
|
373,000
|
|
|
| Investments, at fair value: |
[4],[17],[20] |
|
|
|
|
$ 373,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[16],[19] |
|
|
|
|
1.35%
|
1.35%
|
1.35%
|
| Principal amount |
[16],[19] |
|
|
|
|
$ 31,904,000
|
|
|
| Investment cost |
[2],[16],[19] |
|
|
|
|
32,005,000
|
|
|
| Investments, at fair value: |
[16],[19] |
|
|
|
|
$ 32,542,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, Cap rate 10.35%, PIK Interest 2.15%, 7.06% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[4],[5],[6],[8],[16],[19],[23] |
|
|
|
|
1.35%
|
1.35%
|
1.35%
|
| Principal amount |
[3],[4],[5],[8],[16],[19],[23] |
|
|
|
|
$ 140,460,000
|
|
|
| Investment cost |
[2],[3],[4],[5],[8],[16],[19],[23] |
|
|
|
|
145,207,000
|
|
|
| Investments, at fair value: |
[3],[4],[5],[8],[16],[19],[23] |
|
|
|
|
$ 147,718,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc., Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[7],[8],[16] |
|
|
|
|
1.75%
|
1.75%
|
1.75%
|
| Principal amount |
[4],[7],[8],[16] |
|
|
|
|
$ 32,378,000
|
|
|
| Investment cost |
[2],[4],[7],[8],[16] |
|
|
|
|
33,205,000
|
|
|
| Investments, at fair value: |
[4],[7],[8],[16] |
|
|
|
|
$ 33,280,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Savara, Inc. and Senior Secured and Maturity Date April 2030 and Prime + 1.45%, Floor rate 7.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[4],[5],[6] |
|
|
|
|
1.45%
|
1.45%
|
1.45%
|
| Principal amount |
[3],[4],[5] |
|
|
|
|
$ 21,450,000
|
|
|
| Investment cost |
[2],[3],[4],[5] |
|
|
|
|
21,565,000
|
|
|
| Investments, at fair value: |
[3],[4],[5] |
|
|
|
|
$ 21,548,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and SynOx Therapeutics Limited, Senior Secured, Maturity Date May 2027, Prime + 1.40%, Floor rate 9.90%, 7.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[13],[17] |
|
|
|
|
1.40%
|
1.40%
|
1.40%
|
| Principal amount |
[4],[13],[17] |
|
|
|
|
$ 4,500,000
|
|
|
| Investment cost |
[2],[4],[13],[17] |
|
|
|
|
4,635,000
|
|
|
| Investments, at fair value: |
[4],[13],[17] |
|
|
|
|
4,646,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Total Phathom Pharmaceuticals, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
172,364,000
|
|
|
| Investment cost |
[2] |
|
|
|
|
177,212,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
$ 180,260,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, Maturity Date October 2030, Prime + 1.45%, Floor rate 8.95%, Cap rate 9.45%, 6.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[7],[11] |
|
|
|
|
1.45%
|
1.45%
|
1.45%
|
| Principal amount |
[4],[7],[11] |
|
|
|
|
$ 24,500,000
|
|
|
| Investment cost |
[2],[4],[7],[11] |
|
|
|
|
24,366,000
|
|
|
| Investments, at fair value: |
[4],[7],[11] |
|
|
|
|
$ 24,366,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 10.15%, 3.72% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[8],[13] |
|
|
|
|
3.15%
|
3.15%
|
3.15%
|
| Principal amount |
[7],[8],[13] |
|
|
|
|
$ 75,000,000
|
|
|
| Investment cost |
[2],[7],[8],[13] |
|
|
|
|
76,459,000
|
|
|
| Investments, at fair value: |
[7],[8],[13] |
|
|
|
|
$ 76,524,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc., Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[16],[17] |
|
|
|
|
0.75%
|
0.75%
|
0.75%
|
| Principal amount |
[4],[16],[17] |
|
|
|
|
$ 16,111,000
|
|
|
| Investment cost |
[2],[4],[16],[17] |
|
|
|
|
16,510,000
|
|
|
| Investments, at fair value: |
[4],[16],[17] |
|
|
|
|
$ 16,672,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V., Senior Secured, Maturity Date October 2030, Prime + 2.45%, Floor rate 9.45%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[13],[17] |
|
|
|
|
2.45%
|
2.45%
|
2.45%
|
| Principal amount |
[4],[13],[17] |
|
|
|
|
$ 27,500,000
|
|
|
| Investment cost |
[2],[4],[13],[17] |
|
|
|
|
27,409,000
|
|
|
| Investments, at fair value: |
[4],[13],[17] |
|
|
|
|
$ 28,064,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, Maturity Date December 2028, Prime + 3.00%, Floor rate 9.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[13] |
|
|
|
|
3.00%
|
3.00%
|
3.00%
|
| Principal amount |
[3],[5],[13] |
|
|
|
|
$ 65,000,000
|
|
|
| Investment cost |
[2],[3],[5],[13] |
|
|
|
|
65,186,000
|
|
|
| Investments, at fair value: |
[3],[5],[13] |
|
|
|
|
65,543,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Energy Technologies Total Electric Hydrogen Co. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[9] |
|
|
|
|
30,384,000
|
|
|
| Investment cost |
[2],[9] |
|
|
|
|
30,296,000
|
|
|
| Investments, at fair value: |
[9] |
|
|
|
|
$ 30,201,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Energy Technologies and Electric Hydrogen Co., Senior Secured, Maturity Date May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6],[9],[16],[18] |
|
|
|
|
2.25%
|
2.25%
|
2.25%
|
| Principal amount |
[3],[9],[16],[18] |
|
|
|
|
$ 12,769,000
|
|
|
| Investment cost |
[2],[3],[9],[16],[18] |
|
|
|
|
12,718,000
|
|
|
| Investments, at fair value: |
[3],[9],[16],[18] |
|
|
|
|
$ 12,559,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Energy Technologies and Electric Hydrogen Co., Senior Secured, Maturity Date May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6],[9],[16],[18] |
|
|
|
|
2.25%
|
2.25%
|
2.25%
|
| Principal amount |
[3],[9],[16],[18] |
|
|
|
|
$ 17,615,000
|
|
|
| Investment cost |
[2],[3],[9],[16],[18] |
|
|
|
|
17,578,000
|
|
|
| Investments, at fair value: |
[3],[9],[16],[18] |
|
|
|
|
$ 17,642,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Financial Technologies and Finix Payments, Inc., Senior Secured, December 2029, Prime + 2.50%, Floor rate 9.25%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[5],[6],[11] |
|
|
|
|
2.50%
|
2.50%
|
2.50%
|
| Principal amount |
[5],[9],[11] |
|
|
|
|
$ 7,000,000
|
|
|
| Investment cost |
[2],[5],[9],[11] |
|
|
|
|
6,889,000
|
|
|
| Investments, at fair value: |
[5],[9],[11] |
|
|
|
|
$ 6,889,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Belong Health, Inc. and Senior Secured and Maturity Date November 2029 and Prime + 2.25%, Floor rate 9.75%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[5],[6] |
|
|
|
|
2.25%
|
2.25%
|
2.25%
|
| Principal amount |
[5] |
|
|
|
|
$ 11,250,000
|
|
|
| Investment cost |
[2],[5] |
|
|
|
|
10,950,000
|
|
|
| Investments, at fair value: |
[5] |
|
|
|
|
$ 10,950,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[8],[13],[16] |
|
|
|
|
5.11%
|
5.11%
|
5.11%
|
| Principal amount |
[7],[8],[13],[16] |
|
|
|
|
$ 75,547,000
|
|
|
| Investment cost |
[2],[7],[8],[13],[16] |
|
|
|
|
75,265,000
|
|
|
| Investments, at fair value: |
[7],[8],[13],[16] |
|
|
|
|
$ 73,386,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and ChenMed, LLC, Senior Secured, Maturity Date May 2030, Prime + 2.45%, Floor rate 9.45%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[11],[19] |
|
|
|
|
2.45%
|
2.45%
|
2.45%
|
| Principal amount |
[11],[19] |
|
|
|
|
$ 130,000,000
|
|
|
| Investment cost |
[2],[11],[19] |
|
|
|
|
128,101,000
|
|
|
| Investments, at fair value: |
[11],[19] |
|
|
|
|
$ 128,240,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Curana Health Holdings, LLC, Senior Secured, Maturity Date January 2028, Prime + 1.45%, Floor rate 9.20%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[7],[11],[18] |
|
|
|
|
1.45%
|
1.45%
|
1.45%
|
| Principal amount |
[7],[11],[18] |
|
|
|
|
$ 27,500,000
|
|
|
| Investment cost |
[2],[7],[11],[18] |
|
|
|
|
28,111,000
|
|
|
| Investments, at fair value: |
[7],[11],[18] |
|
|
|
|
$ 28,412,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Ennoble Care LLC and Senior Secured and Maturity Date February 2030 and Prime + 2.60%, Floor rate 10.35%, 7.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6] |
|
|
|
|
2.60%
|
2.60%
|
2.60%
|
| Principal amount |
[3],[5] |
|
|
|
|
$ 13,500,000
|
|
|
| Investment cost |
[2],[3],[5] |
|
|
|
|
13,473,000
|
|
|
| Investments, at fair value: |
[3],[5] |
|
|
|
|
$ 13,548,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2028, Prime + 5.85%, Floor rate 9.50%, PIK Interest 1.95%, 1.27% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[8],[13],[16] |
|
|
|
|
5.85%
|
5.85%
|
5.85%
|
| Principal amount |
[8],[13],[16] |
|
|
|
|
$ 71,943,000
|
|
|
| Investment cost |
[2],[8],[13],[16] |
|
|
|
|
72,286,000
|
|
|
| Investments, at fair value: |
[8],[13],[16] |
|
|
|
|
$ 72,193,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6],[7] |
|
|
|
|
1.95%
|
1.95%
|
1.95%
|
| Principal amount |
[3],[7] |
|
|
|
|
$ 73,500,000
|
|
|
| Investment cost |
[2],[3],[7] |
|
|
|
|
75,009,000
|
|
|
| Investments, at fair value: |
[3],[7] |
|
|
|
|
$ 75,007,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 0.75%, Floor rate 8.75%, PIK Interest 2.25%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[11],[16],[19] |
|
|
|
|
0.75%
|
0.75%
|
0.75%
|
| Principal amount |
[11],[16],[19] |
|
|
|
|
$ 178,230,000
|
|
|
| Investment cost |
[2],[11],[16],[19] |
|
|
|
|
178,449,000
|
|
|
| Investments, at fair value: |
[11],[16],[19] |
|
|
|
|
$ 176,337,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC, Senior Secured, Maturity Date February 2029, Prime + 3.00%, Floor rate 11.00% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[11],[19] |
|
|
|
|
3.00%
|
3.00%
|
3.00%
|
| Principal amount |
[11],[19] |
|
|
|
|
$ 5,000,000
|
|
|
| Investment cost |
[2],[11],[19] |
|
|
|
|
5,000,000
|
|
|
| Investments, at fair value: |
[11],[19] |
|
|
|
|
5,000,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
|
|
|
|
183,230,000
|
|
|
| Investment cost |
[2] |
|
|
|
|
183,449,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
$ 181,337,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and NeueHealth, Inc., Maturity Date June 2028, Prime + 1.15%, Floor rate 9.65%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[8],[16] |
|
|
|
|
1.15%
|
1.15%
|
1.15%
|
| Principal amount |
[8],[16] |
|
|
|
|
$ 46,393,000
|
|
|
| Investment cost |
[2],[8],[16] |
|
|
|
|
44,817,000
|
|
|
| Investments, at fair value: |
[8],[16] |
|
|
|
|
$ 45,469,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Octave Health Group, Inc. and Senior Secured and Maturity Date October 2029, Prime + 2.70%, Floor rate 9.95%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[5],[6],[11] |
|
|
|
|
2.70%
|
2.70%
|
2.70%
|
| Principal amount |
[5],[11] |
|
|
|
|
$ 10,000,000
|
|
|
| Investment cost |
[2],[5],[11] |
|
|
|
|
9,768,000
|
|
|
| Investments, at fair value: |
[5],[11] |
|
|
|
|
$ 9,768,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Tungsten Health Holdings, LLC and Senior Secured and Maturity Date December 2029 and Prime + 1.00%, Floor rate 8.50%, Cap rate 9.00%, PIK Interest 1.25%, 8.35% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6] |
|
|
|
|
1.00%
|
1.00%
|
1.00%
|
| Principal amount |
|
|
|
|
|
$ 10,125,000
|
|
|
| Investment cost |
[2] |
|
|
|
|
10,033,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
$ 10,033,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and WellBe Senior Medical LLC, Senior Secured, Maturity Date May 2029, Prime + 0.75%, Floor rate 7.75%, PIK Interest 2.65%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[6],[16] |
|
|
|
|
0.75%
|
0.75%
|
0.75%
|
| Principal amount |
[3],[16] |
|
|
|
|
$ 33,050,000
|
|
|
| Investment cost |
[2],[3],[16] |
|
|
|
|
33,239,000
|
|
|
| Investments, at fair value: |
[3],[16] |
|
|
|
|
$ 32,690,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Elation Health, Inc., Senior Secured, April 2029, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.30%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[9],[10],[11],[13],[16],[18] |
|
|
|
|
1.75%
|
1.75%
|
1.75%
|
| Principal amount |
[9],[10],[11],[13],[16],[18] |
|
|
|
|
$ 13,575,000
|
|
|
| Investment cost |
[2],[9],[10],[11],[13],[16],[18] |
|
|
|
|
13,283,000
|
|
|
| Investments, at fair value: |
[9],[10],[11],[13],[16],[18] |
|
|
|
|
$ 13,477,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Imagen Technologies, Inc., Senior Secured, November 2028, Prime + 1.55%, Floor rate 9.05%, PIK Interest 1.00%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[5],[6],[9],[10],[11],[16] |
|
|
|
|
1.55%
|
1.55%
|
1.55%
|
| Principal amount |
[5],[9],[10],[11],[16] |
|
|
|
|
$ 7,501,000
|
|
|
| Investment cost |
[2],[5],[9],[10],[11],[16] |
|
|
|
|
7,360,000
|
|
|
| Investments, at fair value: |
[5],[9],[10],[11],[16] |
|
|
|
|
$ 7,360,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Saama Technologies, LLC, Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[8],[9],[11],[16] |
|
|
|
|
0.70%
|
0.70%
|
0.70%
|
| Principal amount |
[8],[9],[11],[16] |
|
|
|
|
$ 22,123,000
|
|
|
| Investment cost |
[2],[8],[9],[11],[16] |
|
|
|
|
22,297,000
|
|
|
| Investments, at fair value: |
[8],[9],[11],[16] |
|
|
|
|
$ 22,689,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Streamline Healthcare Solutions, Senior Secured, June 2030, 3-month SOFR + 7.30%, Floor rate 8.30% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[7],[9],[10],[11],[12],[13] |
|
|
|
|
7.30%
|
7.30%
|
7.30%
|
| Principal amount |
[3],[5],[7],[9],[10],[11],[12],[13] |
|
|
|
|
$ 21,000,000
|
|
|
| Investment cost |
[2],[3],[5],[7],[9],[10],[11],[12],[13] |
|
|
|
|
20,403,000
|
|
|
| Investments, at fair value: |
[3],[5],[7],[9],[10],[11],[12],[13] |
|
|
|
|
$ 20,443,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Healthcare Technology & Digital Health and Vida Health, Inc., Senior Secured, Maturity Date January 2028, Prime - 2.75%, Floor rate 5.75%, PIK Interest 5.35%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[9],[13],[16] |
|
|
|
|
(2.75%)
|
(2.75%)
|
(2.75%)
|
| Principal amount |
[9],[13],[16] |
|
|
|
|
$ 38,798,000
|
|
|
| Investment cost |
[2],[9],[13],[16] |
|
|
|
|
40,005,000
|
|
|
| Investments, at fair value: |
[9],[13],[16] |
|
|
|
|
$ 39,714,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and VulcanForms Inc. and Senior Secured, Maturity Date January 2028, Prime + 4.25%, Floor rate 11.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[13],[18] |
|
|
|
|
4.25%
|
4.25%
|
4.25%
|
| Principal amount |
[13],[18] |
|
|
|
|
$ 20,000,000
|
|
|
| Investment cost |
[2],[13],[18] |
|
|
|
|
20,088,000
|
|
|
| Investments, at fair value: |
[13],[18] |
|
|
|
|
$ 19,941,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Senior Secured, Maturity Date November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6] |
|
|
|
|
2.00%
|
2.00%
|
2.00%
|
| Principal amount |
[3],[5] |
|
|
|
|
$ 15,000,000
|
|
|
| Investment cost |
[2],[3],[5] |
|
|
|
|
15,036,000
|
|
|
| Investments, at fair value: |
[3],[5] |
|
|
|
|
$ 15,132,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, Maturity Date August 2029, Prime + 2.40%, Floor rate 9.90%, 13.40% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[13] |
|
|
|
|
2.40%
|
2.40%
|
2.40%
|
| Principal amount |
[13] |
|
|
|
|
$ 30,625,000
|
|
|
| Investment cost |
[2],[13] |
|
|
|
|
31,441,000
|
|
|
| Investments, at fair value: |
[13] |
|
|
|
|
$ 31,252,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Sight Sciences, Inc., Senior Secured, Maturity Date July 2028, Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[5],[6],[8] |
|
|
|
|
2.35%
|
2.35%
|
2.35%
|
| Principal amount |
[5],[8] |
|
|
|
|
$ 28,000,000
|
|
|
| Investment cost |
[2],[5],[8] |
|
|
|
|
28,398,000
|
|
|
| Investments, at fair value: |
[5],[8] |
|
|
|
|
$ 28,387,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Space Technologies and HawkEye 360, Inc. and Senior Secured and Maturity Date December 2028 and Prime + 2.10%, Floor rate 9.35%, PIK Interest 1.50%, 1.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[18] |
|
|
|
|
2.10%
|
2.10%
|
2.10%
|
| Principal amount |
[18] |
|
|
|
|
$ 8,013,000
|
|
|
| Investment cost |
[2],[18] |
|
|
|
|
7,674,000
|
|
|
| Investments, at fair value: |
[18] |
|
|
|
|
$ 7,674,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Space Technologies and Loft Orbital Solutions Inc. and Senior Secured and Maturity Date December 2029 and Prime + 1.75%, Floor rate 8.75%, PIK Interest 1.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[11],[16],[18] |
|
|
|
|
1.75%
|
1.75%
|
1.75%
|
| Principal amount |
[11],[16],[18] |
|
|
|
|
$ 8,820,000
|
|
|
| Investment cost |
[2],[11],[16],[18] |
|
|
|
|
8,579,000
|
|
|
| Investments, at fair value: |
[11],[16],[18] |
|
|
|
|
$ 8,579,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Space Technologies and Stoke Space Technologies, Inc., Senior Secured, Maturity Date May 2029, Prime + 1.00%, Floor rate 7.50%, PIK Interest 2.00%, 5.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[16] |
|
|
|
|
1.00%
|
1.00%
|
1.00%
|
| Principal amount |
[3],[5],[16] |
|
|
|
|
$ 28,294,000
|
|
|
| Investment cost |
[2],[3],[5],[16] |
|
|
|
|
27,440,000
|
|
|
| Investments, at fair value: |
[3],[5],[16] |
|
|
|
|
$ 27,539,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Tidal Vision Products, Inc. and Senior Secured and Maturity Date October 2028 and Prime + 2.45%, Floor rate 9.70%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[5],[6],[11] |
|
|
|
|
2.45%
|
2.45%
|
2.45%
|
| Principal amount |
[5],[11] |
|
|
|
|
$ 5,000,000
|
|
|
| Investment cost |
[2],[5],[11] |
|
|
|
|
4,736,000
|
|
|
| Investments, at fair value: |
[5],[11] |
|
|
|
|
$ 4,736,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Armis, Inc. and Senior Secured and Maturity Date March 2028 and Prime + 0.00%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[8],[10],[16],[19] |
|
|
|
|
0.00%
|
0.00%
|
0.00%
|
| Principal amount |
[8],[10],[16],[19] |
|
|
|
|
$ 51,771,000
|
|
|
| Investment cost |
[2],[8],[10],[16],[19] |
|
|
|
|
51,909,000
|
|
|
| Investments, at fair value: |
[8],[10],[16],[19] |
|
|
|
|
$ 52,896,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Armis, Inc. and Senior Secured and Maturity Date March 2028 and Prime + 1.25%, Floor rate 8.75%, PIK Interest 2.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[13],[16],[19] |
|
|
|
|
1.25%
|
1.25%
|
1.25%
|
| Principal amount |
[10],[13],[16],[19] |
|
|
|
|
$ 101,183,000
|
|
|
| Investment cost |
[2],[10],[13],[16],[19] |
|
|
|
|
100,789,000
|
|
|
| Investments, at fair value: |
[10],[13],[16],[19] |
|
|
|
|
$ 102,916,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and CoreView USA, Inc. and Senior Secured and Maturity Date January 2029 and Prime + 2.75%, Floor rate 9.25%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[5],[6],[10],[11] |
|
|
|
|
2.75%
|
2.75%
|
2.75%
|
| Principal amount |
[5],[10],[11] |
|
|
|
|
$ 25,000,000
|
|
|
| Investment cost |
[2],[5],[10],[11] |
|
|
|
|
25,045,000
|
|
|
| Investments, at fair value: |
[5],[10],[11] |
|
|
|
|
$ 24,978,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Harness, Inc. and Senior Secured and Maturity Date March 2029 and Prime - 2.25%, Floor rate 5.25%, Cap rate 6.50%, PIK Interest 6.25%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11],[16],[18] |
|
|
|
|
(2.25%)
|
(2.25%)
|
(2.25%)
|
| Principal amount |
[10],[11],[16],[18] |
|
|
|
|
$ 57,906,000
|
|
|
| Investment cost |
[2],[10],[11],[16],[18] |
|
|
|
|
57,378,000
|
|
|
| Investments, at fair value: |
[10],[11],[16],[18] |
|
|
|
|
$ 58,967,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and New Relic, Inc. and Senior Secured and Maturity Date November 2030 and 3-month SOFR + 6.75%, Floor rate 7.75% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[6],[10],[11] |
|
|
|
|
6.75%
|
6.75%
|
6.75%
|
| Principal amount |
[10],[11] |
|
|
|
|
$ 21,890,000
|
|
|
| Investment cost |
[2],[10],[11] |
|
|
|
|
21,465,000
|
|
|
| Investments, at fair value: |
[10],[11] |
|
|
|
|
$ 21,491,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and PayIt, LLC and Senior Secured and Maturity Date December 2028 and Prime + 1.45%, Floor rate 7.95%, PIK Interest 1.50%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[3],[5],[6],[10],[11],[16],[18] |
|
|
|
|
1.45%
|
1.45%
|
1.45%
|
| Principal amount |
[3],[5],[10],[11],[16],[18] |
|
|
|
|
$ 26,271,000
|
|
|
| Investment cost |
[2],[3],[5],[10],[11],[16],[18] |
|
|
|
|
26,218,000
|
|
|
| Investments, at fair value: |
[3],[5],[10],[11],[16],[18] |
|
|
|
|
$ 25,868,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Scylla DB Ltd. and Senior Secured and Maturity Date July 2029 and Prime + 3.00%, Floor rate 10.50%, 0.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[4],[6],[10],[17] |
|
|
|
|
3.00%
|
3.00%
|
3.00%
|
| Principal amount |
[4],[10],[17] |
|
|
|
|
$ 15,000,000
|
|
|
| Investment cost |
[2],[4],[10],[17] |
|
|
|
|
14,798,000
|
|
|
| Investments, at fair value: |
[4],[10],[17] |
|
|
|
|
14,700,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments System Software and Total Armis, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[10] |
|
|
|
|
152,954,000
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
152,698,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
155,812,000
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Alchemer LLC, Senior Secured, May 2028, 1-month SOFR + 7.89%, Floor rate 8.89% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[25],[26],[27] |
7.89%
|
|
7.89%
|
7.89%
|
|
|
|
| Principal amount |
[24],[25],[26] |
$ 20,003,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[25],[26] |
19,829,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[25],[26] |
$ 19,674,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, AlphaSense, Inc., Senior Secured, June 2029, 1-month SOFR + 6.25% , Floor rate 8.25% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27] |
6.25%
|
|
6.25%
|
6.25%
|
|
|
|
| Principal amount |
|
$ 37,128,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
37,128,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 37,871,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, AlphaSense, Inc., Senior Secured, June 2029, 3-month SOFR + 6.25%, Floor rate 8.25% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28] |
6.25%
|
|
6.25%
|
6.25%
|
|
|
|
| Principal amount |
[28] |
$ 20,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28] |
19,877,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28] |
$ 20,400,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Annex Cloud, Senior Secured, September 2026, PIK Interest 3-month SOFR + 9.99%, Floor rate 10.99% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[29],[30],[31] |
9.99%
|
|
9.99%
|
9.99%
|
|
|
|
| Principal amount |
[29],[30],[31] |
$ 3,325,000
|
|
|
|
|
|
|
| Investment cost |
[1],[29],[30],[31] |
3,325,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[29],[30],[31] |
$ 3,036,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Babel Street, Senior Secured, December 2027, 3-month SOFR + 8.01%, Floor rate 9.01% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[26],[27],[32] |
8.01%
|
|
8.01%
|
8.01%
|
|
|
|
| Principal amount |
[25],[26],[32] |
$ 64,845,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[26],[32] |
64,258,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[26],[32] |
$ 63,953,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Brain Corporation, Senior Secured, September 2028, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.50%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[33] |
1.35%
|
|
1.35%
|
1.35%
|
|
|
|
| Principal amount |
[24],[33] |
$ 33,460,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[33] |
33,787,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[33] |
$ 34,012,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Ceros, Inc., Senior Secured, June 2027, 3-month SOFR + 8.99%, Floor rate 9.89% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[26],[27] |
8.99%
|
|
8.99%
|
8.99%
|
|
|
|
| Principal amount |
[26] |
$ 22,656,000
|
|
|
|
|
|
|
| Investment cost |
[1],[26] |
22,599,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[26] |
$ 22,380,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Chainalysis, Inc., Senior Secured, June 2029, Prime + 2.95%, Floor rate 10.45% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27] |
2.95%
|
|
2.95%
|
2.95%
|
|
|
|
| Principal amount |
|
$ 39,413,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
39,040,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 39,891,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Dashlane, Inc., Senior Secured, December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[28],[34] |
3.05%
|
|
3.05%
|
3.05%
|
|
|
|
| Principal amount |
[24],[28],[34] |
$ 43,369,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[28],[34] |
44,640,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[28],[34] |
$ 45,081,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, DevRev, Inc., Senior Secured, July 2029, Prime + 3.95%, Floor rate 10.70%, Cap rate 14.70%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27] |
3.95%
|
|
3.95%
|
3.95%
|
|
|
|
| Principal amount |
|
$ 36,500,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
36,246,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 36,247,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Distributed Creation Inc., Senior Secured, April 2029, Prime + 3.00%, Floor rate 10.25%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28] |
3.00%
|
|
3.00%
|
3.00%
|
|
|
|
| Principal amount |
[28] |
$ 40,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28] |
39,948,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28] |
$ 39,878,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, DocPlanner, Senior Secured, January 2030, Prime + 2.75%, Floor rate 9.75%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[36] |
2.75%
|
|
2.75%
|
2.75%
|
|
|
|
| Principal amount | € |
[35],[36] |
|
|
€ 68,200
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
$ 70,406,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
$ 77,535,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Earnix, Inc., Senior Secured, June 2029, Prime - 1.15%, Floor rate 5.35%, PIK Interest 4.45% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[28],[33] |
(1.15%)
|
|
(1.15%)
|
(1.15%)
|
|
|
|
| Principal amount |
[25],[28],[33] |
$ 20,739,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[28],[33] |
20,525,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[28],[33] |
$ 20,946,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Funnel Holding AB (publ), Senior Secured, October 2029, Prime + 0.60%, Floor rate 7.10%, Cap rate 8.60%, PIK Interest 3.00%, 2.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33],[34],[35],[36] |
0.60%
|
|
0.60%
|
0.60%
|
|
|
|
| Principal amount |
[25],[33],[34],[35],[36] |
$ 21,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33],[34],[35],[36] |
21,337,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33],[34],[35],[36] |
21,339,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Khoros, LLC, Senior Secured, May 2030 , FIXED 10.00% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
11,469,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
11,469,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 10,941,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, LinenMaster, LLC, Senior Secured, August 2029, 1-month SOFR + 8.28%, Floor rate 9.28% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[26],[27] |
8.28%
|
|
8.28%
|
8.28%
|
|
|
|
| Principal amount |
[25],[26] |
$ 11,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[26] |
11,234,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[26] |
$ 11,500,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Loftware, Inc., Senior Secured, March 2028, 3-month SOFR + 7.75%, Floor rate 8.75% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[26],[27] |
7.75%
|
|
7.75%
|
7.75%
|
|
|
|
| Principal amount |
[25],[26] |
$ 29,511,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[26] |
29,225,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[26] |
$ 29,511,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Mango Technologies, Inc., Senior Secured, August 2030, Prime + 2.25%, Floor rate 8.25%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[37] |
2.25%
|
|
2.25%
|
2.25%
|
|
|
|
| Principal amount |
[25],[37] |
$ 62,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[37] |
61,250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[37] |
$ 61,464,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Marigold Group, Inc., Senior Secured, April 2028, 3-month SOFR + 9.50%, Floor rate 10.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[33],[34] |
9.50%
|
|
9.50%
|
9.50%
|
|
|
|
| Principal amount |
[24],[33],[34] |
$ 45,739,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[33],[34] |
45,308,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[33],[34] |
$ 44,520,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Microblink LLC, Senior Secured, August 2027, 3-month SOFR + 7.84%, Floor rate 8.84% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[26],[27] |
7.84%
|
|
7.84%
|
7.84%
|
|
|
|
| Principal amount |
[26] |
$ 5,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[26] |
4,929,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[26] |
$ 4,929,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Omeda Holdings, LLC, Senior Secured, July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[26],[27],[28] |
8.05%
|
|
8.05%
|
8.05%
|
|
|
|
| Principal amount |
[26],[28] |
$ 6,602,000
|
|
|
|
|
|
|
| Investment cost |
[1],[26],[28] |
6,554,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[26],[28] |
$ 6,554,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Pindrop Security, Inc., Senior Secured, June 2029, Prime + 3.50%, Floor rate 10.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[32] |
3.50%
|
|
3.50%
|
3.50%
|
|
|
|
| Principal amount |
[25],[32] |
$ 31,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[32] |
30,921,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[32] |
$ 31,813,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Proven Optics, LLC, Senior Secured, December 2030, 3-month SOFR + 7.30%, Floor rate 8.30% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[26],[27] |
7.30%
|
|
7.30%
|
7.30%
|
|
|
|
| Principal amount |
[25],[26] |
$ 15,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[26] |
14,759,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[26] |
$ 14,899,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Remodel Health Holdco, LLC, Senior Secured, December 2028, Prime + 2.35%, Floor rate 10.35%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[38] |
2.35%
|
|
2.35%
|
2.35%
|
|
|
|
| Principal amount |
[32],[38] |
$ 25,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38] |
25,461,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38] |
$ 25,869,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Reveleer, Senior Secured, February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.60% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[33],[38] |
0.65%
|
|
0.65%
|
0.65%
|
|
|
|
| Principal amount |
[32],[33],[38] |
$ 50,819,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[33],[38] |
52,977,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33],[38] |
$ 52,977,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Sisense Ltd., Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[35],[36] |
1.50%
|
|
1.50%
|
1.50%
|
|
|
|
| Principal amount |
[33],[35],[36] |
$ 26,744,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[35],[36] |
28,054,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[35],[36] |
$ 27,070,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Smartsheet Inc., Senior Secured, January 2031, 3-month SOFR + 5.25%, Floor rate 6.00% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27] |
5.25%
|
|
5.25%
|
5.25%
|
|
|
|
| Principal amount |
[25] |
$ 46,785,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25] |
46,056,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25] |
$ 47,370,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Snappt, Inc., Senior Secured, April 2029, Prime + 2.35%, Floor rate 8.85%, PIK Interest 1.00%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[33],[38] |
2.35%
|
|
2.35%
|
2.35%
|
|
|
|
| Principal amount |
[32],[33],[38] |
$ 22,049,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[33],[38] |
22,155,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33],[38] |
$ 21,646,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Suzy, Inc., Senior Secured, June 2028, Prime - 2.00%, Floor rate 5.00%, PIK Interest 6.95%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[33],[38] |
(2.00%)
|
|
(2.00%)
|
(2.00%)
|
|
|
|
| Principal amount |
[32],[33],[38] |
$ 22,986,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[33],[38] |
23,314,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33],[38] |
$ 13,209,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Tipalti Solutions Ltd., Senior Secured, April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33],[39] |
0.45%
|
|
0.45%
|
0.45%
|
|
|
|
| Principal amount |
[25],[33],[39] |
$ 73,767,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33],[39] |
73,488,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33],[39] |
$ 72,775,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Tipalti Solutions Ltd., Senior Secured, April 2029, Prime + 0.45%, Floor rate 6.45%, PIK Interest 2.30%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33],[39] |
0.45%
|
|
0.45%
|
0.45%
|
|
|
|
| Principal amount |
[25],[33],[39] |
$ 43,426,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33],[39] |
43,762,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33],[39] |
44,052,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Total AlphaSense, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
57,128,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
57,005,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
58,271,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Total Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
117,193,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
117,250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
116,827,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Total iSpot.tv, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
42,670,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
42,922,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 43,147,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Ushur, Inc., Senior Secured, June 2028, Prime + 2.20%, Floor rate 9.20%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[38] |
2.20%
|
|
2.20%
|
2.20%
|
|
|
|
| Principal amount |
[32],[38] |
$ 14,150,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38] |
14,200,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38] |
$ 13,949,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, Zappi, Inc., Senior Secured, December 2027, 6-month SOFR + 8.03%, Floor rate 9.03% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[25],[26],[27],[35],[36] |
8.03%
|
|
8.03%
|
8.03%
|
|
|
|
| Principal amount |
[24],[25],[26],[35],[36] |
$ 12,504,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[25],[26],[35],[36] |
12,411,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[25],[26],[35],[36] |
$ 12,449,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, ZeroEyes, Inc., Senior Secured, May 2030, Prime + 2.00%, Floor rate 9.50%, PIK Interest 2.00%, 1.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[33],[38] |
2.00%
|
|
2.00%
|
2.00%
|
|
|
|
| Principal amount |
[32],[33],[38] |
$ 21,182,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[33],[38] |
20,926,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33],[38] |
$ 20,513,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, iSpot.tv, Inc., Senior Secured, January 2029, Prime + 1.40%, Floor rate 8.15%, PIK Interest 0.75%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33],[37] |
1.40%
|
|
1.40%
|
1.40%
|
|
|
|
| Principal amount |
[25],[33],[37] |
$ 39,363,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33],[37] |
39,574,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33],[37] |
$ 39,806,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, iSpot.tv, Inc., Senior Secured, January 2029, Prime + 2.25%, Floor rate 9.00%, PIK Interest 1.00%, 5.70% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33] |
2.25%
|
|
2.25%
|
2.25%
|
|
|
|
| Principal amount |
[25],[33] |
$ 3,307,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33] |
3,348,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33] |
$ 3,341,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Application Software, micro1 Inc., Senior Secured, June 2029, Prime + 3.50%, Floor rate 10.25%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[34],[38] |
3.50%
|
|
3.50%
|
3.50%
|
|
|
|
| Principal amount |
[34],[38] |
$ 20,750,000
|
|
|
|
|
|
|
| Investment cost |
[1],[34],[38] |
20,232,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[34],[38] |
$ 20,232,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Biotechnology Tools, Antheia, Inc., Senior Secured, August 2029, Prime + 2.85%, Floor rate 10.35%, 5.55% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28] |
2.85%
|
|
2.85%
|
2.85%
|
|
|
|
| Principal amount |
[28] |
$ 21,250,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28] |
20,323,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28] |
$ 20,059,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Biotechnology Tools, NorthStar Medical Technologies, LLC, Senior Secured, October 2030, Prime + 3.10%, Floor rate 9.35%, Cap rate 10.35%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[38] |
3.10%
|
|
3.10%
|
3.10%
|
|
|
|
| Principal amount |
[38] |
$ 48,750,000
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
48,237,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
$ 48,237,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Communications & Networking, Aryaka Networks, Inc., Senior Secured, December 2028, Prime + 1.80%, Floor rate 9.30%, PIK Interest 1.25%, 5.68% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[37] |
1.80%
|
|
1.80%
|
1.80%
|
|
|
|
| Principal amount |
[33],[37] |
$ 28,541,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[37] |
29,214,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[37] |
$ 23,670,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Communications & Networking, Tarana Wireless, Inc., Senior Secured, March 2030, Prime + 4.00%, Floor rate 10.75%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[34],[38] |
4.00%
|
|
4.00%
|
4.00%
|
|
|
|
| Principal amount |
[34],[38] |
$ 10,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[34],[38] |
9,893,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[34],[38] |
$ 9,963,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Products, Tonal Systems, Inc., Senior Secured, March 2029, Prime + 4.25%, Floor rate 11.00%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[34] |
4.25%
|
|
4.25%
|
4.25%
|
|
|
|
| Principal amount |
[34] |
$ 19,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[34] |
18,923,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[34] |
$ 19,171,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Products, Weee! Inc., Senior Secured, April 2028, Prime + 2.25%, Floor rate 9.75%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[28] |
2.25%
|
|
2.25%
|
2.25%
|
|
|
|
| Principal amount |
[25],[28] |
$ 20,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[28] |
20,001,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[28] |
$ 19,877,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Andesa Services, Inc., Senior Secured, March 2031, 1-month SOFR + 7.80%, Floor rate 8.80% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[26],[27] |
7.80%
|
|
7.80%
|
7.80%
|
|
|
|
| Principal amount |
[25],[26] |
$ 10,931,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[26] |
10,707,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[26] |
$ 10,720,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, AppDirect, Inc., Senior Secured, September 2029, Prime + 2.05%, Floor rate 8.55%, PIK Interest 1.00%, 4.70% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33] |
2.05%
|
|
2.05%
|
2.05%
|
|
|
|
| Principal amount |
[33] |
$ 65,022,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33] |
64,863,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33] |
$ 64,562,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Carwow LTD, Senior Secured, December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[35],[36] |
4.70%
|
|
4.70%
|
4.70%
|
|
|
|
| Principal amount | £ |
[33],[35],[36] |
|
|
|
£ 20,892
|
|
|
|
| Investment cost |
[1],[33],[35],[36] |
$ 29,122,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[35],[36] |
$ 28,391,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, GoEuro Travel GmbH, Senior Secured, November 2029, Prime + 3.45%, Floor rate 10.45%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[36] |
3.45%
|
|
3.45%
|
3.45%
|
|
|
|
| Principal amount |
[35],[36] |
$ 58,036,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
58,371,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
58,410,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Houzz, Inc., Convertible Debt, May 2028, PIK Interest 12.00% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[33],[40] |
31,611,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[40] |
31,611,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[40] |
$ 30,316,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Jobandtalent USA, Inc., Senior Secured, October 2028, 1-month SOFR + 1.00%, Floor rate 1.00%, PIK Interest 9.00% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[35],[36] |
1.00%
|
|
1.00%
|
1.00%
|
|
|
|
| Principal amount |
[33],[35],[36] |
$ 1,094,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[35],[36] |
1,094,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[35],[36] |
$ 1,094,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Jobandtalent USA, Inc., Senior Secured, October 2028, 1-month SOFR + 3.50%, Floor rate 4.50%, PIK Interest 3.25%, 10.47% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[31],[33],[35],[36] |
3.50%
|
|
3.50%
|
3.50%
|
|
|
|
| Principal amount |
[31],[33],[35],[36] |
$ 14,652,000
|
|
|
|
|
|
|
| Investment cost |
[1],[31],[33],[35],[36] |
15,466,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[31],[33],[35],[36] |
$ 10,166,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Nerdy Inc., Senior Secured, November 2029, Prime + 3.50%, Floor rate 10.75%, 7.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27] |
3.50%
|
|
3.50%
|
3.50%
|
|
|
|
| Principal amount |
|
$ 21,000,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
20,990,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 20,781,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Peek Travel, Inc., Senior Secured, October 2028, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33] |
1.75%
|
|
1.75%
|
1.75%
|
|
|
|
| Principal amount |
[33] |
$ 26,409,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33] |
26,306,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33] |
$ 25,986,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Perk International Holdings Ltd, Senior Secured, May 2031, 3-month SOFR + 7.00%, Floor rate 9.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[35],[36] |
7.00%
|
|
7.00%
|
7.00%
|
|
|
|
| Principal amount |
[25],[35],[36] |
$ 14,938,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[35],[36] |
14,651,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[35],[36] |
$ 14,651,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Provi, Senior Secured, December 2027, Prime + 4.40%, Floor rate 10.65%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32] |
4.40%
|
|
4.40%
|
4.40%
|
|
|
|
| Principal amount |
[32] |
$ 14,160,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
14,315,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
$ 14,311,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 9.50%, Floor rate 10.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[32],[33] |
9.50%
|
|
9.50%
|
9.50%
|
|
|
|
| Principal amount |
[24],[32],[33] |
$ 25,809,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[32],[33] |
25,797,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[32],[33] |
$ 25,797,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Riviera Partners LLC, Senior Secured, March 2028, 3-month SOFR + 8.28%, Floor rate 9.28% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[26],[27] |
8.28%
|
|
8.28%
|
8.28%
|
|
|
|
| Principal amount |
[26] |
$ 35,850,000
|
|
|
|
|
|
|
| Investment cost |
[1],[26] |
35,660,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[26] |
$ 35,850,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Skyword, Inc., Senior Secured, November 2027, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[33] |
2.75%
|
|
2.75%
|
2.75%
|
|
|
|
| Principal amount |
[24],[33] |
$ 6,306,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[33] |
6,640,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[33] |
6,486,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Tectura Corporation, Senior Secured, January 2027, FIXED 8.25% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[41] |
8,250,000
|
|
|
|
|
|
|
| Investment cost |
[1],[41] |
8,250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
8,250,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Consumer & Business Services, Total Jobandtalent USA, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
15,746,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
16,560,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 11,260,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Akeyless Security Ltd., Senior Secured, August 2028, Prime + 4.00%, Floor rate 11.00%, 2.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[36],[42] |
4.00%
|
|
4.00%
|
4.00%
|
|
|
|
| Principal amount |
[35],[36],[42] |
$ 15,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[42] |
14,918,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[42] |
$ 14,981,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Coronet Cyber Security Ltd., Senior Secured, October 2028, Prime + 2.90%, Floor rate 9.40% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[42] |
2.90%
|
|
2.90%
|
2.90%
|
|
|
|
| Principal amount |
[42] |
$ 7,464,000
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
7,395,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
$ 7,205,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, DNSFilter, Inc., Senior Secured, October 2028, Prime + 2.15%, Floor rate 8.65%, PIK Interest 0.75%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33],[34],[42] |
2.15%
|
|
2.15%
|
2.15%
|
|
|
|
| Principal amount |
[25],[33],[34],[42] |
$ 7,540,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33],[34],[42] |
7,545,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33],[34],[42] |
$ 7,551,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Expel, Inc., Senior Secured, April 2029, Prime + 3.90%, Floor rate 10.65%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[42] |
3.90%
|
|
3.90%
|
3.90%
|
|
|
|
| Principal amount |
[25],[42] |
$ 11,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[42] |
10,934,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[42] |
$ 10,773,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, LogRhythm, Inc., Senior Secured, July 2029, 3-month SOFR + 7.50%, Floor rate 8.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[42] |
7.50%
|
|
7.50%
|
7.50%
|
|
|
|
| Principal amount |
[33],[42] |
$ 26,609,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[42] |
26,139,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[42] |
$ 15,236,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, LogRhythm, Inc., Senior Secured, October 2026, 3-month SOFR + 5.50%, Floor rate 6.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[42] |
5.50%
|
|
5.50%
|
5.50%
|
|
|
|
| Principal amount |
[42] |
$ 438,000
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
438,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
$ 438,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Morphisec Information Security 2014 Ltd., Senior Secured, October 2027, Prime + 3.45%, Floor rate 11.70%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[36],[42] |
3.45%
|
|
3.45%
|
3.45%
|
|
|
|
| Principal amount |
[35],[36],[42] |
$ 11,435,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[42] |
11,848,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[42] |
$ 11,642,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Semperis Technologies Inc., Senior Secured, April 2029, Prime + 2.50%, Floor rate 9.00%, PIK Interest 1.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[34],[42] |
2.50%
|
|
2.50%
|
2.50%
|
|
|
|
| Principal amount |
[33],[34],[42] |
$ 24,892,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[34],[42] |
24,661,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[34],[42] |
$ 24,921,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Semperis Technologies Inc., Senior Secured, April 2029, Prime - 0.50%, Floor rate 8.00%, PIK Interest 3.85% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[34],[42] |
(0.50%)
|
|
(0.50%)
|
(0.50%)
|
|
|
|
| Principal amount |
[33],[34],[42] |
$ 34,818,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[34],[42] |
34,437,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[34],[42] |
$ 34,553,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Semperis Technologies Inc., Senior Secured, April 2029, Prime - 1.75%, Floor rate 6.75%, PIK Interest 3.25% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[33],[34],[42] |
(1.75%)
|
|
(1.75%)
|
(1.75%)
|
|
|
|
| Principal amount |
[28],[33],[34],[42] |
$ 24,099,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[33],[34],[42] |
23,939,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[33],[34],[42] |
$ 24,014,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Sumo Logic, Inc., Senior Secured, May 2030, 3-month SOFR + 6.50%, Floor rate 7.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33],[42] |
6.50%
|
|
6.50%
|
6.50%
|
|
|
|
| Principal amount |
[25],[33],[42] |
$ 23,943,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33],[42] |
23,591,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33],[42] |
23,078,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Total LogRhythm, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[42] |
27,047,000
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
26,577,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
15,674,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Total Semperis Technologies Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[42] |
83,809,000
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
83,037,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
83,488,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Total Zimperium, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[42] |
19,462,000
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
19,390,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
$ 19,390,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Zimperium, Inc., Senior Secured, May 2027, 3-month SOFR + 5.39%, Floor rate 6.39% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[26],[27],[42] |
5.39%
|
|
5.39%
|
5.39%
|
|
|
|
| Principal amount |
[25],[26],[42] |
$ 1,766,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[26],[42] |
1,756,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[26],[42] |
$ 1,756,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Cybersecurity, Zimperium, Inc., Senior Secured, May 2027, 3-month SOFR + 8.10%, Floor rate 9.10% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[26],[27],[42] |
8.10%
|
|
8.10%
|
8.10%
|
|
|
|
| Principal amount |
[25],[26],[42] |
$ 17,696,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[26],[42] |
17,634,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[26],[42] |
$ 17,634,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Defense Technologies, Allen Control Systems Inc., Senior Secured, September 2030, Prime + 3.25%, Floor rate 9.50%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[34] |
3.25%
|
|
3.25%
|
3.25%
|
|
|
|
| Principal amount |
[34] |
$ 14,583,000
|
|
|
|
|
|
|
| Investment cost |
[1],[34] |
14,149,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[34] |
$ 14,149,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Defense Technologies, Hermeus Corporation, Senior Secured, March 2030, Prime + 2.75%, Floor rate 10.00%, PIK Interest 1.00%, 4.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[28],[33] |
2.75%
|
|
2.75%
|
2.75%
|
|
|
|
| Principal amount |
[25],[28],[33] |
$ 15,768,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[28],[33] |
15,348,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[28],[33] |
$ 15,520,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Defense Technologies, Saronic Technologies, Inc., Senior Secured, June 2030, Prime + 2.50%, Floor rate 9.00%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[32],[38],[39] |
2.50%
|
|
2.50%
|
2.50%
|
|
|
|
| Principal amount |
[25],[32],[38],[39] |
$ 115,914,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[32],[38],[39] |
114,277,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[32],[38],[39] |
$ 119,391,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Defense Technologies, Shield AI, Inc., Senior Secured, February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[37],[39] |
0.85%
|
|
0.85%
|
0.85%
|
|
|
|
| Principal amount |
[33],[37],[39] |
$ 148,122,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[37],[39] |
148,415,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[37],[39] |
151,660,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Diversified Financial Services, Gibraltar Acquisition LLC, Unsecured, July 2029, FIXED 11.50% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[33],[41],[43] |
28,805,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[41],[43] |
28,486,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[41],[43] |
28,486,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Diversified Financial Services, Gibraltar Acquisition LLC, Unsecured, July 2029, FIXED 11.95% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[41],[43] |
10,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[41],[43] |
9,871,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[41],[43] |
9,871,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Diversified Financial Services, Hercules Adviser LLC, Unsecured, March 2027, FIXED 6.75% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[41],[44] |
8,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[41],[44] |
8,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[41],[44] |
8,000,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Diversified Financial Services, Total Gibraltar Acquisition LLC |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
38,805,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
38,357,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 38,357,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, 4D Molecular Therapeutics, Inc., Senior Secured, June 2031, Prime + 2.00%, Floor rate 8.75%, Cap rate 9.50%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[35],[38] |
2.00%
|
|
2.00%
|
2.00%
|
|
|
|
| Principal amount |
[25],[35],[38] |
$ 14,200,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[35],[38] |
14,111,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[35],[38] |
$ 14,111,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Altimmune, Inc., Senior Secured, June 2029, Prime + 2.45%, Floor rate 9.70%, 6.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[35],[38] |
2.45%
|
|
2.45%
|
2.45%
|
|
|
|
| Principal amount |
[32],[35],[38] |
$ 17,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[35],[38] |
17,701,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[35],[38] |
$ 17,800,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Arcus Biosciences, Inc., Senior Secured, September 2030, Prime - 0.05%, Floor rate 8.45%, PIK Interest 2.20%, 9.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[32],[33],[35],[38] |
(0.05%)
|
|
(0.05%)
|
(0.05%)
|
|
|
|
| Principal amount |
[28],[32],[33],[35],[38] |
$ 76,981,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[32],[33],[35],[38] |
78,337,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[32],[33],[35],[38] |
$ 81,786,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Beren Therapeutics P.B.C., Senior Secured, October 2029, Prime + 2.45%, Floor rate 9.95%, 5.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[38] |
2.45%
|
|
2.45%
|
2.45%
|
|
|
|
| Principal amount |
[28],[38] |
$ 17,250,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[38] |
17,080,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[38] |
$ 16,936,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Braeburn, Inc., Senior Secured, October 2028, Prime + 3.00%, Floor rate 10.50%, PIK Interest 0.25%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33] |
3.00%
|
|
3.00%
|
3.00%
|
|
|
|
| Principal amount |
[33] |
$ 53,735,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33] |
55,118,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33] |
$ 56,524,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, COMPASS Pathways plc, Senior Secured, January 2031, Prime + 2.75%, Floor rate 9.75%, 7.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[35],[36] |
2.75%
|
|
2.75%
|
2.75%
|
|
|
|
| Principal amount |
[28],[35],[36] |
$ 42,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[35],[36] |
42,758,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[35],[36] |
$ 43,833,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Disc Medicine, Inc., Senior Secured, December 2029, Prime + 1.75%, Floor rate 8.25%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[32],[35],[38] |
1.75%
|
|
1.75%
|
1.75%
|
|
|
|
| Principal amount |
[25],[32],[35],[38] |
$ 34,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[32],[35],[38] |
34,377,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[32],[35],[38] |
$ 35,726,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Dyne Therapeutics, Inc., Senior Secured, July 2030, Prime + 2.45%, Floor rate 9.95%, 5.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[35],[37],[38],[39] |
2.45%
|
|
2.45%
|
2.45%
|
|
|
|
| Principal amount |
[32],[35],[37],[38],[39] |
$ 125,615,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[35],[37],[38],[39] |
125,751,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[35],[37],[38],[39] |
$ 128,465,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Heron Therapeutics, Inc., Senior Secured, September 2030, Prime + 1.95%, Floor rate 9.45%, PIK Interest 1.00%, 6.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[33] |
1.95%
|
|
1.95%
|
1.95%
|
|
|
|
| Principal amount |
[32],[33] |
$ 68,316,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[33] |
68,668,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33] |
$ 68,264,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Kura Oncology, Inc., Senior Secured, November 2027, Prime + 2.40%, Floor rate 8.65%, 6.05% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[35] |
2.40%
|
|
2.40%
|
2.40%
|
|
|
|
| Principal amount |
[32],[35] |
$ 5,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[35] |
5,763,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[35] |
$ 5,882,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Lexicon Pharmaceuticals, Inc., Senior Secured, May 2030, Prime + 3.10%, Floor rate 9.85%, 6.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[37],[38] |
3.10%
|
|
3.10%
|
3.10%
|
|
|
|
| Principal amount |
[35],[37],[38] |
$ 38,875,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[37],[38] |
38,384,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[37],[38] |
$ 38,384,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Maze Therapeutics, Inc., Senior Secured, February 2031, Prime + 0.95%, Floor rate 7.95%, 6.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[28],[35],[38] |
0.95%
|
|
0.95%
|
0.95%
|
|
|
|
| Principal amount |
[25],[28],[35],[38] |
$ 27,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[28],[35],[38] |
26,954,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[28],[35],[38] |
$ 27,588,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, MoonLake Immunotherapeutics, Senior Secured, April 2030, Prime + 1.45%, Floor rate 8.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[36] |
1.45%
|
|
1.45%
|
1.45%
|
|
|
|
| Principal amount |
[35],[36] |
$ 46,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
46,382,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
47,397,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, NorthSea Therapeutics, Convertible Debt, June 2027, FIXED 6.00% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[35],[36],[40] |
473,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[40] |
473,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[40] |
$ 473,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Phathom Pharmaceuticals, Inc., Senior Secured, February 2029, Prime + 3.10%, Floor rate 9.85%, 2.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[37],[38],[39],[45] |
3.10%
|
|
3.10%
|
3.10%
|
|
|
|
| Principal amount |
[35],[37],[38],[39],[45] |
$ 131,832,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[37],[38],[39],[45] |
131,312,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[37],[38],[39],[45] |
$ 133,179,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Replimune Group, Inc., Senior Secured, October 2029, Prime + 1.75%, Floor rate 8.50%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[25],[27],[33],[35],[37] |
1.75%
|
|
1.75%
|
1.75%
|
|
|
|
| Principal amount |
[24],[25],[33],[35],[37] |
$ 67,970,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[25],[33],[35],[37] |
69,288,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[25],[33],[35],[37] |
$ 70,118,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Rocket Pharmaceuticals, Inc., Senior Secured, October 2030, Prime + 2.40%, Floor rate 9.15%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[35],[38] |
2.40%
|
|
2.40%
|
2.40%
|
|
|
|
| Principal amount |
[25],[35],[38] |
$ 26,250,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[35],[38] |
25,563,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[35],[38] |
$ 25,563,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Savara, Inc., Senior Secured, April 2030, Prime + 1.45%, Floor rate 7.45%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[35],[38] |
1.45%
|
|
1.45%
|
1.45%
|
|
|
|
| Principal amount |
[32],[35],[38] |
$ 21,450,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[35],[38] |
21,815,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[35],[38] |
$ 22,245,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, SynOx Therapeutics Limited, Senior Secured, May 2028, Prime + 1.40%, Floor rate 9.90%, 7.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[35],[36] |
1.40%
|
|
1.40%
|
1.40%
|
|
|
|
| Principal amount |
[28],[35],[36] |
$ 10,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[35],[36] |
10,662,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[35],[36] |
$ 10,741,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Tenpoint Therapeutics Limited, Senior Secured, October 2029, Prime + 2.90%, Floor rate 10.40%, 6.65% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[35],[36] |
2.90%
|
|
2.90%
|
2.90%
|
|
|
|
| Principal amount |
[28],[35],[36] |
$ 18,750,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[35],[36] |
18,833,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[35],[36] |
18,367,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, Total X4 Pharmaceuticals, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
75,000,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
77,246,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 78,538,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, X4 Pharmaceuticals, Inc., Senior Secured, July 2027, Prime + 3.15%, Floor rate 10.15%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[37] |
3.15%
|
|
3.15%
|
3.15%
|
|
|
|
| Principal amount |
[24],[37] |
$ 42,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[37] |
43,717,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[37] |
$ 44,413,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, X4 Pharmaceuticals, Inc., Senior Secured, July 2027, Prime + 3.15%, Floor rate 10.15%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[28],[37] |
3.15%
|
|
3.15%
|
3.15%
|
|
|
|
| Principal amount |
[24],[28],[37] |
$ 32,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[28],[37] |
33,529,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[28],[37] |
$ 34,125,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, enGene Therapeutics Inc. (p.k.a. enGene, Inc.), Senior Secured, January 2030, Prime + 2.25%, Floor rate 9.25%, Cap rate 10.25%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[36] |
2.25%
|
|
2.25%
|
2.25%
|
|
|
|
| Principal amount |
[35],[36] |
$ 17,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
18,032,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
$ 18,079,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Drug Discovery & Development, uniQure B.V., Senior Secured, October 2030, Prime + 2.45%, Floor rate 9.45%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[35],[36] |
2.45%
|
|
2.45%
|
2.45%
|
|
|
|
| Principal amount |
[28],[35],[36] |
$ 27,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[35],[36] |
27,728,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[35],[36] |
$ 28,404,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Electronics & Computer Hardware, Locus Robotics Corp., Senior Secured, December 2028, Prime + 3.00%, Floor rate 9.50%, 4.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[32],[37],[38] |
3.00%
|
|
3.00%
|
3.00%
|
|
|
|
| Principal amount |
[28],[32],[37],[38] |
$ 65,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[32],[37],[38] |
65,694,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[32],[37],[38] |
$ 65,831,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Antares Nuclear, Inc., Senior Secured 1, September 2030, Prime + 2.75%, Floor rate 9.50%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[42] |
2.75%
|
|
2.75%
|
2.75%
|
|
|
|
| Principal amount |
[25],[42] |
$ 4,219,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[42] |
4,090,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[42] |
$ 4,090,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Antares Nuclear, Inc., Senior Secured 2, September 2030, Prime + 2.75%, Floor rate 9.50%, 1.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[42],[46] |
2.75%
|
|
2.75%
|
2.75%
|
|
|
|
| Principal amount |
[25],[42],[46] |
$ 469,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[42],[46] |
454,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[42],[46] |
$ 454,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 5.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[33],[34],[42] |
2.25%
|
|
2.25%
|
2.25%
|
|
|
|
| Principal amount |
[32],[33],[34],[42] |
$ 12,891,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[33],[34],[42] |
13,088,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33],[34],[42] |
$ 12,971,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 7.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[33],[34],[42] |
2.25%
|
|
2.25%
|
2.25%
|
|
|
|
| Principal amount |
[32],[33],[34],[42] |
$ 17,777,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[33],[34],[42] |
18,179,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33],[34],[42] |
$ 18,015,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Renew Home, LLC, Senior Secured, March 2030, Prime + 3.00%, Floor rate 9.25%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[34],[42] |
3.00%
|
|
3.00%
|
3.00%
|
|
|
|
| Principal amount |
[25],[34],[42] |
$ 4,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[34],[42] |
4,012,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[34],[42] |
4,020,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Total Antares Nuclear, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[42] |
4,688,000
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
4,544,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
4,544,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Total Electric Hydrogen Co. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
[42] |
30,668,000
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
31,267,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
$ 30,986,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Energy Technologies, Valar Atomics Inc., Senior Secured, August 2029, Prime + 4.35%, Floor rate 11.10% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[42],[46] |
4.35%
|
|
4.35%
|
4.35%
|
|
|
|
| Principal amount |
[42],[46] |
$ 19,444,000
|
|
|
|
|
|
|
| Investment cost |
[1],[42],[46] |
19,218,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42],[46] |
19,218,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Equipment Financing |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
|
35,900,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 37,400,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Financial Technologies, Finix Payments, Inc., Senior Secured, December 2029, Prime + 2.50%, Floor rate 9.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[38],[42] |
2.50%
|
|
2.50%
|
2.50%
|
|
|
|
| Principal amount |
[25],[38],[42] |
$ 24,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[38],[42] |
24,294,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[38],[42] |
$ 24,400,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Belong Health, Inc., Senior Secured, November 2029, Prime + 2.25%, Floor rate 9.75%, 5.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[38] |
2.25%
|
|
2.25%
|
2.25%
|
|
|
|
| Principal amount |
[25],[38] |
$ 11,250,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[38] |
11,097,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[38] |
$ 11,094,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Blue Sprig Pediatrics, Inc., Senior Secured, May 2029, 1-month SOFR + 7.75%, Floor rate 10.75%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[28],[37] |
7.75%
|
|
7.75%
|
7.75%
|
|
|
|
| Principal amount |
[24],[28],[37] |
$ 67,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[28],[37] |
66,918,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[28],[37] |
$ 65,677,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, ChenMed, LLC, Senior Secured, May 2030, Prime + 2.45%, Floor rate 9.45%, 3.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[39] |
2.45%
|
|
2.45%
|
2.45%
|
|
|
|
| Principal amount |
[25],[39] |
$ 130,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[39] |
129,058,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[39] |
$ 129,351,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Connections Health Holdings, LLC, Senior Secured, May 2030, Prime + 1.20%, Floor rate 7.95%, PIK Interest 1.00%, 6.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33],[38] |
1.20%
|
|
1.20%
|
1.20%
|
|
|
|
| Principal amount |
[25],[33],[38] |
$ 7,521,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33],[38] |
7,391,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33],[38] |
$ 7,391,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Consensus Intermediate Holdco, LLC, Senior Secured, June 2030, Prime + 3.20%, Floor rate 9.95%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[38] |
3.20%
|
|
3.20%
|
3.20%
|
|
|
|
| Principal amount |
[38] |
$ 14,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
13,883,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
$ 13,883,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Curana Health Holdings, LLC, Senior Secured, October 2029, Prime + 1.45%, Floor rate 9.20%, 7.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[34] |
1.45%
|
|
1.45%
|
1.45%
|
|
|
|
| Principal amount |
[24],[34] |
$ 60,750,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[34] |
61,810,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[34] |
$ 62,210,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Ennoble Care LLC, Senior Secured, February 2030, Prime + 2.60%, Floor rate 10.35%, 7.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[38] |
2.60%
|
|
2.60%
|
2.60%
|
|
|
|
| Principal amount |
[32],[38] |
$ 60,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38] |
59,985,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38] |
$ 60,573,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Equality Health, LLC, Senior Secured, February 2028, Prime + 5.85%, Floor rate 9.50%, PIK Interest 1.95% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[33],[37] |
5.85%
|
|
5.85%
|
5.85%
|
|
|
|
| Principal amount |
[28],[33],[37] |
$ 73,018,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[33],[37] |
72,684,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[33],[37] |
$ 71,989,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Main Street Rural, Inc., Senior Secured, July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[32],[37] |
1.95%
|
|
1.95%
|
1.95%
|
|
|
|
| Principal amount |
[24],[32],[37] |
$ 73,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[32],[37] |
76,682,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[32],[37] |
$ 76,682,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Marathon Health, LLC, Senior Secured, February 2029, Prime + 0.25%, Floor rate 8.25%, PIK Interest 2.25%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33],[39] |
0.25%
|
|
0.25%
|
0.25%
|
|
|
|
| Principal amount |
[25],[33],[39] |
$ 185,989,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33],[39] |
187,183,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33],[39] |
$ 186,736,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, NeueHealth, Inc., Senior Secured, June 2028, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[37] |
3.65%
|
|
3.65%
|
3.65%
|
|
|
|
| Principal amount |
[33],[37] |
$ 89,376,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[37] |
87,784,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[37] |
$ 87,191,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Octave Health Group, Inc., Senior Secured, October 2029, Prime + 2.70%, Floor rate 9.95%, 5.35% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[38] |
2.70%
|
|
2.70%
|
2.70%
|
|
|
|
| Principal amount |
[38] |
$ 12,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
12,365,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
$ 12,397,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Strive Health Holdings, LLC, Senior Secured, August 2029, Prime + 1.05%, Floor rate 9.55%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[37] |
1.05%
|
|
1.05%
|
1.05%
|
|
|
|
| Principal amount |
[32],[37] |
$ 36,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[37] |
36,234,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[37] |
$ 36,407,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, The Good Health Group, LLC, Senior Secured, June 2030, Prime + 3.45%, Floor rate 10.20%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27] |
3.45%
|
|
3.45%
|
3.45%
|
|
|
|
| Principal amount |
|
$ 18,125,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
18,008,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 18,008,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, Tungsten Health Holdings, LLC, Senior Secured, December 2029, Prime + 1.00%, Floor rate 8.50%, Cap rate 9.00%, PIK Interest 1.25%, 8.35% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33] |
1.00%
|
|
1.00%
|
1.00%
|
|
|
|
| Principal amount |
[33] |
$ 23,711,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33] |
23,644,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33] |
$ 23,879,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Services, Other, WellBe Senior Medical, LLC, Senior Secured, May 2029, Prime + 2.00%, Floor rate 9.00%, PIK Interest 1.40%, 6.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[33] |
2.00%
|
|
2.00%
|
2.00%
|
|
|
|
| Principal amount |
[32],[33] |
$ 33,722,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[33] |
34,277,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33] |
$ 33,869,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, CollectiveHealth, Inc., Senior Secured, February 2030, Prime + 3.50%, Floor rate 10.25%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[42] |
3.50%
|
|
3.50%
|
3.50%
|
|
|
|
| Principal amount |
[25],[42] |
$ 10,125,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[42] |
10,068,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[42] |
$ 9,861,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Elation Health, Inc., Senior Secured, April 2029, Prime + 1.75%, Floor rate 9.25%, PIK Interest 1.30%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[28],[33],[34],[42] |
1.75%
|
|
1.75%
|
1.75%
|
|
|
|
| Principal amount |
[25],[28],[33],[34],[42] |
$ 21,257,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[28],[33],[34],[42] |
21,062,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[28],[33],[34],[42] |
$ 21,240,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Imagen Technologies, Inc., Senior Secured, November 2028, Prime + 1.55%, Floor rate 9.05%, PIK Interest 1.00%, 3.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[38],[42] |
1.55%
|
|
1.55%
|
1.55%
|
|
|
|
| Principal amount |
[33],[38],[42] |
$ 7,558,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[38],[42] |
7,529,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[38],[42] |
$ 7,607,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Modern Life, Inc., Senior Secured, February 2029, Prime + 2.75%, Floor rate 10.25%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[27],[42] |
2.75%
|
|
2.75%
|
2.75%
|
|
|
|
| Principal amount |
[24],[42] |
$ 18,429,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[42] |
18,711,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[42] |
$ 18,605,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Saama Technologies, LLC, Senior Secured, July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[33],[37],[42] |
0.70%
|
|
0.70%
|
0.70%
|
|
|
|
| Principal amount |
[33],[37],[42] |
$ 24,408,000
|
|
|
|
|
|
|
| Investment cost |
[1],[33],[37],[42] |
24,850,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[33],[37],[42] |
$ 24,850,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, SonderMind Inc., Senior Secured, July 2030, Prime + 2.75%, Floor rate 9.50%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[28],[38],[42] |
2.75%
|
|
2.75%
|
2.75%
|
|
|
|
| Principal amount |
[25],[28],[38],[42] |
$ 29,490,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[28],[38],[42] |
29,256,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[28],[38],[42] |
$ 29,256,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Healthcare Technology & Digital Health, Streamline Healthcare Solutions, Senior Secured, June 2030, 3-month SOFR + 7.30%, Floor rate 8.30% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[24],[25],[26],[27],[28],[32],[38],[42] |
7.30%
|
|
7.30%
|
7.30%
|
|
|
|
| Principal amount |
[24],[25],[26],[28],[32],[38],[42] |
$ 22,260,000
|
|
|
|
|
|
|
| Investment cost |
[1],[24],[25],[26],[28],[32],[38],[42] |
21,743,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[24],[25],[26],[28],[32],[38],[42] |
21,914,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Manufacturing Technology, Total VulcanForms Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
36,240,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
36,543,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 38,752,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Manufacturing Technology, VulcanForms Inc., Senior Secured, February 2029, Prime + 0.00%, Floor rate 6.75%, 9.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[46] |
0.00%
|
|
0.00%
|
0.00%
|
|
|
|
| Principal amount |
[46] |
$ 16,240,000
|
|
|
|
|
|
|
| Investment cost |
[1],[46] |
16,230,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[46] |
$ 17,702,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Manufacturing Technology, VulcanForms Inc., Senior Secured, January 2028, Prime + 4.25%, Floor rate 11.25%, 4.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[34] |
4.25%
|
|
4.25%
|
4.25%
|
|
|
|
| Principal amount |
[28],[34] |
$ 20,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[34] |
20,313,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[34] |
$ 21,050,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Cognito Therapeutics Group, Inc., Senior Secured, January 2030, Prime + 2.70%, Floor rate 9.95%, 5.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[38] |
2.70%
|
|
2.70%
|
2.70%
|
|
|
|
| Principal amount |
[38] |
$ 3,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
3,392,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
$ 3,374,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Orchestra BioMed Holdings, Inc., Senior Secured, November 2028, Prime + 2.00%, Floor rate 9.50%, 6.35% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[38] |
2.00%
|
|
2.00%
|
2.00%
|
|
|
|
| Principal amount |
[32],[38] |
$ 15,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38] |
15,274,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38] |
$ 15,408,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Senseonics Holdings, Inc., Senior Secured, August 2029, Prime + 2.40%, Floor rate 9.90%, 13.40% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[28],[37] |
2.40%
|
|
2.40%
|
2.40%
|
|
|
|
| Principal amount |
[28],[37] |
$ 30,625,000
|
|
|
|
|
|
|
| Investment cost |
[1],[28],[37] |
32,189,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[28],[37] |
$ 32,696,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Senseonics Holdings, Inc., Senior Secured, August 2029, Prime + 2.40%, Floor rate 9.90%, 6.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[37] |
2.40%
|
|
2.40%
|
2.40%
|
|
|
|
| Principal amount |
[35],[37] |
$ 15,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[37] |
15,382,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[37] |
$ 15,592,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Sight Sciences, Inc., Senior Secured, July 2028, Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[37],[38] |
2.35%
|
|
2.35%
|
2.35%
|
|
|
|
| Principal amount |
[37],[38] |
$ 28,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[37],[38] |
28,837,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[37],[38] |
29,051,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, Total Senseonics Holdings, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
46,125,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
47,571,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 48,288,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Medical Devices & Equipment, restor3d, Inc., Senior Secured, October 2031, Prime + 2.65%, Floor rate 9.15%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[38] |
2.65%
|
|
2.65%
|
2.65%
|
|
|
|
| Principal amount |
[38] |
$ 18,750,000
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
18,541,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
$ 18,541,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Space Technologies, LeoLabs, Inc., Senior Secured, April 2030, Prime + 2.90%, Floor rate 9.65%, PIK Interest 0.95%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33] |
2.90%
|
|
2.90%
|
2.90%
|
|
|
|
| Principal amount |
[25],[33] |
$ 6,625,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33] |
6,559,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33] |
$ 6,559,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Space Technologies, Loft Orbital Solutions Inc., Senior Secured, December 2029, Prime + 1.75%, Floor rate 8.75%, PIK Interest 1.00%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33],[34] |
1.75%
|
|
1.75%
|
1.75%
|
|
|
|
| Principal amount |
[25],[33],[34] |
$ 9,657,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33],[34] |
9,493,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33],[34] |
$ 9,609,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Space Technologies, Stoke Space Technologies, Inc., Senior Secured, May 2029, Prime + 1.00%, Floor rate 7.50%, PIK Interest 2.00%, 5.25% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[32],[33],[38] |
1.00%
|
|
1.00%
|
1.00%
|
|
|
|
| Principal amount |
[32],[33],[38] |
$ 28,720,000
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[33],[38] |
28,514,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[33],[38] |
$ 29,095,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, Sustainable and Renewable Technology, Tidal Vision Products, Inc., Senior Secured, October 2028, Prime + 2.45%, Floor rate 9.70%, 3.45% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[38] |
2.45%
|
|
2.45%
|
2.45%
|
|
|
|
| Principal amount |
[25],[38] |
$ 7,500,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[38] |
7,240,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[38] |
$ 7,332,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, ControlUp, Inc., Senior Secured, January 2031, Prime + 0.25%, Floor rate 6.75%, PIK Interest 2.00%, 3.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[33] |
0.25%
|
|
0.25%
|
0.25%
|
|
|
|
| Principal amount |
[25],[33] |
$ 10,135,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[33] |
10,069,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[33] |
$ 10,129,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, CoreView USA, Inc., Senior Secured, January 2029, Prime + 2.50%, Floor rate 9.00%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27] |
2.50%
|
|
2.50%
|
2.50%
|
|
|
|
| Principal amount |
|
$ 10,000,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
9,897,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
$ 10,112,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, CoreView USA, Inc., Senior Secured, January 2029, Prime + 2.75%, Floor rate 9.25%, 4.95% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[38] |
2.75%
|
|
2.75%
|
2.75%
|
|
|
|
| Principal amount |
[38] |
$ 25,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
25,307,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
$ 25,546,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, Neo4j, Inc., Senior Secured, April 2030, Prime + 2.60%, Floor rate 9.10%, 3.50% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27] |
2.60%
|
|
2.60%
|
2.60%
|
|
|
|
| Principal amount |
[25] |
$ 9,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25] |
8,910,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25] |
$ 8,990,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, New Relic, Inc., Senior Secured, November 2030, 3-month SOFR + 6.75%, Floor rate 7.75% |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27] |
6.75%
|
|
6.75%
|
6.75%
|
|
|
|
| Principal amount |
[25] |
$ 21,890,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25] |
21,517,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25] |
$ 21,633,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, PayIt, LLC, Senior Secured, December 2028, Prime + 1.45%, Floor rate 7.95%, PIK Interest 1.50%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[32],[33],[34],[38] |
1.45%
|
|
1.45%
|
1.45%
|
|
|
|
| Principal amount |
[25],[32],[33],[34],[38] |
$ 26,569,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[32],[33],[34],[38] |
26,783,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[32],[33],[34],[38] |
$ 26,700,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, PayIt, LLC, Senior Secured, December 2028, Prime + 3.00%, Floor rate 10.25%, PIK Interest 1.50%, 5.00% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[25],[27],[32],[33],[34] |
3.00%
|
|
3.00%
|
3.00%
|
|
|
|
| Principal amount |
[25],[32],[33],[34] |
$ 2,813,000
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[32],[33],[34] |
2,796,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[32],[33],[34] |
$ 2,817,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, Scylla DB Ltd., Senior Secured, July 2029, Prime + 3.00%, Floor rate 10.50%, 0.75% Exit Fee |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment, basis spread, variable rate |
[27],[35],[36] |
3.00%
|
|
3.00%
|
3.00%
|
|
|
|
| Principal amount |
[35],[36] |
$ 15,000,000
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
14,856,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
14,730,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, Total CoreView USA, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
35,000,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
35,204,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
35,658,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Debt Investments, System Software, Total PayIt, LLC |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
29,382,000
|
|
|
|
|
|
|
| Investment cost |
[1] |
29,579,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
29,517,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Black Crow AI, Inc. affiliates and Equity and Acquisition Date 3/24/2021 and Preferred Note |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10],[47] |
|
|
|
|
2,846,000
|
|
|
| Investments, at fair value: |
[10],[47] |
|
|
|
|
2,846,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and CapLinked, Inc. and Equity and Acquisition Date 10/26/2012 and Preferred Series A-3 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
51,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and HighRoads, Inc. and Equity and Acquisition Date 1/18/2013 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
307,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Khoros, LLC and Equity and Acquisition Date 5/23/2025 and Earnout Interest |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10],[48] |
|
|
|
|
5,242,000
|
|
|
| Investments, at fair value: |
[10],[48] |
|
|
|
|
3,651,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Khoros, LLC., Equity, Acquisition Date 5/23/2025, Series Earnout Interest |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
|
|
|
|
|
5,200,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
3,700,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Leapwork ApS and Equity and Acquisition Date 8/25/2023 and Preferred Series B2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[10],[17] |
|
|
|
|
250,000
|
|
|
| Investments, at fair value: |
[4],[10],[17] |
|
|
|
|
135,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and Nextdoor.com, Inc. and Equity and Acquisition Date 8/1/2018 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10],[49] |
|
|
|
|
4,854,000
|
|
|
| Investments, at fair value: |
[10],[49] |
|
|
|
|
2,140,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Application Software and SirionLabs Pte. Ltd. and Equity and Acquisition Date 6/30/2024 and Preferred Series F1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[10],[17] |
|
|
|
|
1,792,000
|
|
|
| Investments, at fair value: |
[4],[10],[17] |
|
|
|
|
1,827,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Biotechnology Tools and Alamar Biosciences, Inc., Equity, Acquisition Date 2/21/2024, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,500,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
841,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc. Equity, Acquisition Date 7/16/2013, Series Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,101,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
275,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
128,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
42,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
433,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
14,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
13,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
183,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Total Fabletics, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,229,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
317,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17] |
|
|
|
|
1,151,000
|
|
|
| Investments, at fair value: |
[4],[17] |
|
|
|
|
1,036,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Jobandtalent USA, Inc. and Equity and Acquisition Date 2/11/2025 and Preferred Series F |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17] |
|
|
|
|
563,000
|
|
|
| Investments, at fair value: |
[4],[17] |
|
|
|
|
225,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
5,263,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
1,951,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
1,000,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
104,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,663,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
427,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
39,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,000,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[21] |
|
|
|
|
13,263,000
|
|
|
| Investments, at fair value: |
[21] |
|
|
|
|
1,250,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[21] |
|
|
|
|
900,000
|
|
|
| Investments, at fair value: |
[21] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[21] |
|
|
|
|
0
|
|
|
| Investments, at fair value: |
[21] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
2,295,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
589,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
14,163,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
1,250,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Cybersecurity and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
1,000,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
4,190,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Cybersecurity and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
300,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
873,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Cybersecurity, Total Druva Holdings, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
1,300,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
5,063,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Defense Technologies and Shield AI, Inc., Equity and Acquisition Date 2/7/2025 and Series Preferred Series F1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[19] |
|
|
|
|
2,250,000
|
|
|
| Investments, at fair value: |
[19] |
|
|
|
|
1,284,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition LLC, Equity, Acquisition Date 3/1/2018, Series Member Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[21],[22] |
|
|
|
|
32,456,000
|
|
|
| Investments, at fair value: |
[21],[22] |
|
|
|
|
23,963,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[21],[50] |
|
|
|
|
12,035,000
|
|
|
| Investments, at fair value: |
[21],[50] |
|
|
|
|
43,274,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
403,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
404,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
1,500,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
2,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
500,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
309,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
2,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
1,329,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
10,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Arcus Biosciences, Inc., Equity, Acquisition Date 2/19/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[49] |
|
|
|
|
2,250,000
|
|
|
| Investments, at fair value: |
[4],[49] |
|
|
|
|
4,874,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
1,000,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
1,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/05/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17],[49] |
|
|
|
|
1,871,000
|
|
|
| Investments, at fair value: |
[4],[17],[49] |
|
|
|
|
695,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
1,000,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
2,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[49] |
|
|
|
|
550,000
|
|
|
| Investments, at fair value: |
[4],[49] |
|
|
|
|
308,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dyne Therapeutics, Inc., Equity, Acquisition Date 7/2/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[49] |
|
|
|
|
1,400,000
|
|
|
| Investments, at fair value: |
[4],[49] |
|
|
|
|
3,319,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
500,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
474,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
4,250,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
222,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[49] |
|
|
|
|
550,000
|
|
|
| Investments, at fair value: |
[4],[49] |
|
|
|
|
497,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and MoonLake Immunotherapeutics, Equity, Acquisition Date 11/6/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17],[49] |
|
|
|
|
1,002,000
|
|
|
| Investments, at fair value: |
[4],[17],[49] |
|
|
|
|
1,259,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17] |
|
|
|
|
2,000,000
|
|
|
| Investments, at fair value: |
[4],[17] |
|
|
|
|
1,278,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[19],[49] |
|
|
|
|
1,730,000
|
|
|
| Investments, at fair value: |
[4],[19],[49] |
|
|
|
|
2,443,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rafael Holdings, Inc. (p.k.a. Cyclo Therapeutics, Inc.), Equity, Acquisition Date 4/6/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[49] |
|
|
|
|
42,000
|
|
|
| Investments, at fair value: |
[4],[49] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
1,500,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
3,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
203,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
67,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health, LLC |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
4,000,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
2,222,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Verge Analytics, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,603,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
2,485,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,000,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
827,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
3,000,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
1,395,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 7/2/2025, Series SAFE |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[51] |
|
|
|
|
103,000
|
|
|
| Investments, at fair value: |
[51] |
|
|
|
|
103,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,500,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
2,382,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, Acquisition Date 11/6/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[49] |
|
|
|
|
400,000
|
|
|
| Investments, at fair value: |
[4],[49] |
|
|
|
|
1,005,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
2,945,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
209,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17],[49] |
|
|
|
|
332,000
|
|
|
| Investments, at fair value: |
[4],[17],[49] |
|
|
|
|
411,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
650,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
348,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,500,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
624,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Financial Technologies and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[49] |
|
|
|
|
577,000
|
|
|
| Investments, at fair value: |
[9],[49] |
|
|
|
|
256,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Financial Technologies and Worldremit Group Limited, Equity, Acquisition Date 6/24/2024, Series Preferred Series X |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[9],[17] |
|
|
|
|
922,000
|
|
|
| Investments, at fair value: |
[4],[9],[17] |
|
|
|
|
922,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,910,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Curana Health Holdings, LLC, Equity, Acquisition Date 5/13/2024, Series Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
2,500,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
3,664,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Main Street Rural, Inc., Equity, Acquisition Date 10/28/2024, Series Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
874,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
1,166,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and NH Holdings 2025 SPV, L.P., Equity, Acquisition Date 6/21/2024, Series Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,848,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
2,439,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Strive Health Holdings, LLC, Equity, Acquisition Date 6/27/2025, Series Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
599,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
814,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and WellBe Senior Medical, LLC, Equity, Acquisition Date 6/10/2024, Series Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,600,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
1,762,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Technology & Digital Health and Click Therapeutics, Inc., Equity, Acquisition Date 5/20/2024, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[9] |
|
|
|
|
1,662,000
|
|
|
| Investments, at fair value: |
[3],[9] |
|
|
|
|
2,074,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Technology & Digital Health and DNAnexus, Inc. and Equity and Acquisition Date 3/21/2014 and Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
97,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
8,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Healthcare Technology & Digital Health and Verana Health, Inc. and Equity and Acquisition Date 7/8/2021 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
2,000,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
3,825,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
3,200,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[21] |
|
|
|
|
0
|
|
|
| Investments, at fair value: |
[21] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[21] |
|
|
|
|
250,000
|
|
|
| Investments, at fair value: |
[21] |
|
|
|
|
218,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Equity, Acquisition Date 8/4/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
1,000,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
1,509,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Total Coronado Aesthetics, LLC |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
250,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
218,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 6/26/2015, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
7,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
102,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
160,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
7,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Semiconductors and Total Achronix Semiconductor Corporation |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
167,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
109,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Space Technologies and Stoke Space Technologies, Inc., Equity, Acquisition Date 9/23/2025, Series Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,406,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
1,256,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
2,000,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
106,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
500,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
4,500,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
397,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and SUNation Energy, Inc., Equity, Acquisition Date 12/10/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
3,153,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Armis, Inc., Equity, Acquisition Date 10/18/2024, Series Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10],[19] |
|
|
|
|
2,000,000
|
|
|
| Investments, at fair value: |
[10],[19] |
|
|
|
|
3,860,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[10],[17] |
|
|
|
|
500,000
|
|
|
| Investments, at fair value: |
[4],[10],[17] |
|
|
|
|
919,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[10],[17] |
|
|
|
|
138,000
|
|
|
| Investments, at fair value: |
[4],[10],[17] |
|
|
|
|
330,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
4,284,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
125,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
265,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
19,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments System Software and Total Contentful Global, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
638,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
1,249,000
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Annex Cloud, Equity, 7/10/2026, Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[30] |
7,359,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[30] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Black Crow AI, Inc. affiliates, Equity, 3/24/2021, Preferred Note |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[52] |
3,058,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[52] |
3,058,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, CapLinked, Inc., Equity, 10/26/2012, Preferred Series A-3 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
51,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Khoros, LLC, Equity, 5/23/2025, Earnout Interest |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[53] |
5,242,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[53] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Khoros, LLC., Equity, 5/23/2025, Earnout Interest |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
|
5,200,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Leapwork ApS, Equity, 8/25/2023, Preferred Series B2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
90,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, Nextdoor.com, Inc., Equity, 8/1/2018, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
4,854,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
2,477,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Application Software, micro1 Inc., Equity, 6/26/2026, SAFE |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[55] |
1,813,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[55] |
1,813,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Biotechnology Tools, Alamar Biosciences, Inc., Equity, 2/21/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
1,500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
7,098,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Fabletics, Inc., Equity, 4/30/2010, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
128,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
11,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Fabletics, Inc., Equity, 7/16/2013, Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,101,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
115,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Grove Collaborative, Inc., Equity, 4/30/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
433,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
13,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Savage X Holding, LLC, Equity, 4/30/2010, Class A Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
13,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
176,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Products, Total Fabletics, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,229,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
126,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Carwow LTD, Equity, 12/15/2021, Preferred Series D-4 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
1,151,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
828,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Jobandtalent USA, Inc., Equity, 2/11/2025, Preferred Series F |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
563,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Lyft, Inc., Equity, 12/26/2018, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
5,263,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
1,512,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Nerdy Inc., Equity, 9/17/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
1,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
54,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, OfferUp, Inc., Equity, 10/25/2016, Preferred Series A |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,663,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
302,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, OfferUp, Inc., Equity, 10/25/2016, Preferred Series A-1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
632,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
115,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Reischling Press, Inc., Equity, 7/31/2020, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
39,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Rhino Labs, Inc., Equity, 1/24/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Tectura Corporation, Equity, 12/29/2023, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[41] |
13,263,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
1,522,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Tectura Corporation, Equity, 5/23/2018, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[41] |
900,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Tectura Corporation, Equity, 6/6/2016, Preferred Series BB |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[41] |
0
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Total OfferUp, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
2,295,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
417,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Consumer & Business Services, Total Tectura Corporation |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
14,163,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
1,522,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Cybersecurity, Druva Holdings, Inc., Equity, 10/22/2015, Preferred Series 2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
1,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
4,077,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Cybersecurity, Druva Holdings, Inc., Equity, 8/24/2017, Preferred Series 3 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
300,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
850,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Cybersecurity, Total Druva Holdings, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
1,300,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
4,927,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Defense Technologies, Saronic Technologies, Inc., Equity, 3/27/2026, Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[39] |
4,250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[39] |
4,662,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Defense Technologies, Shield AI, Inc., Equity, 2/7/2025, Preferred Series F1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[39] |
2,250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[39] |
2,825,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Diversified Financial Services, Gibraltar Acquisition LLC, Equity, 3/1/2018, Member Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[41],[43] |
31,456,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[41],[43] |
23,779,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Diversified Financial Services, Hercules Adviser LLC, Equity, 3/26/2021, Member Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[41],[44] |
14,183,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[41],[44] |
41,942,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Delivery, Aytu BioScience, Inc., Equity, 3/28/2014, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
1,500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
2,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Delivery, BioQ Pharma Incorporated, Equity, 12/8/2015, Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Delivery, PDS Biotechnology Corporation, Equity, 4/6/2015, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
309,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
2,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Delivery, Talphera, Inc., Equity, 12/10/2018, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
1,329,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
10,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Arcus Biosciences, Inc., Equity, 2/19/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[54] |
2,250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[54] |
5,283,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Avalo Therapeutics, Inc., Equity, 8/19/2014, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
1,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
1,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Bicycle Therapeutics PLC, Equity, 10/5/2020, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[54] |
1,871,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[54] |
361,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Daré Bioscience, Inc., Equity, 1/8/2015, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
1,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
1,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Dyne Therapeutics, Inc., Equity, 7/2/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[39],[54] |
1,400,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[39],[54] |
2,734,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Heron Therapeutics, Inc., Equity, 7/25/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
114,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Hibercell, Inc., Equity, 5/7/2021, Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
4,250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
176,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Kura Oncology, Inc., Equity, 6/16/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[54] |
550,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[54] |
512,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Maze Therapeutics, Inc., Equity, 4/23/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[54] |
2,056,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[54] |
2,378,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, MoonLake Immunotherapeutics, Equity, 11/6/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[54] |
1,002,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[54] |
1,117,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, NorthSea Therapeutics, Equity, 12/15/2021, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
2,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
563,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Phathom Pharmaceuticals, Inc., Equity, 6/9/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[39],[54] |
1,730,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[39],[54] |
1,075,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Rafael Holdings, Inc., Equity, 4/6/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[54] |
42,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[54] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Rocket Pharmaceuticals, Inc., Equity, 8/22/2007, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
1,500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
3,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Savara, Inc., Equity, 8/11/2015, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
203,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
57,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Total Valo Health, LLC |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
4,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
2,660,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Total Verge Analytics, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,603,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
103,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Valo Health, LLC, Equity, 10/31/2022, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
920,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Valo Health, LLC, Equity, 12/11/2020, Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
3,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
1,740,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Verge Analytics, Inc., Equity, 7/2/2025, SAFE |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[55] |
103,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[55] |
103,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Verge Analytics, Inc., Equity, 9/6/2023, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, Viridian Therapeutics, Inc., Equity, 11/6/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[54] |
400,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[54] |
665,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, X4 Pharmaceuticals, Inc., Equity, 11/26/2019, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
2,945,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
151,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Drug Discovery & Development, uniQure B.V., Equity, 1/31/2019, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[54] |
1,107,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[54] |
827,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Electronics & Computer Hardware, Locus Robotics Corp., Equity, 11/17/2022, Preferred Series F |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
650,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
378,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Electronics & Computer Hardware, Skydio, Inc., Equity, 3/8/2022, Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
811,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Equity, SAFE |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
|
1,900,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
1,900,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Financial Technologies, Hypercore Inc., Equity, 1/22/2026, Preferred Series A-II |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
400,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
378,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Financial Technologies, Oportun, Equity, 6/28/2013, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42],[54] |
577,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42],[54] |
394,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Financial Technologies, Worldremit Group Limited, Equity, 6/24/2024, Preferred Series X |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[42] |
922,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[42] |
515,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Curana Health Holdings, LLC, Equity, 3/26/2026, Class C Non Voting Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
197,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
241,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Curana Health Holdings, LLC, Equity, 5/13/2024, Class B Voting Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
2,500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
3,335,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Main Street Rural, Inc., Equity, 10/28/2024, Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,750,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
2,217,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, NH Holdings 2025 SPV, L.P., Equity, 6/21/2024, Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
2,551,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
546,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Strive Health Holdings, LLC, Equity, 6/27/2025, Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
599,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
962,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, Total Curana Health Holdings, LLC |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
2,697,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
3,576,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Services, Other, WellBe Senior Medical, LLC, Equity, 6/10/2024, Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,600,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
3,086,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Technology & Digital Health, Click Therapeutics, Inc., Equity, 5/20/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[42] |
1,662,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[42] |
2,233,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Technology & Digital Health, DNAnexus, Inc., Equity, 3/21/2014, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
97,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
15,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Healthcare Technology & Digital Health, Verana Health, Inc., Equity, 7/8/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
2,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Information Services, Yipit, LLC, Equity, 12/30/2021, Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
3,825,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
3,759,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Medical Devices & Equipment, Coronado Aesthetics, LLC, Equity, 10/15/2021, Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[41] |
0
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Medical Devices & Equipment, Coronado Aesthetics, LLC, Equity, 10/15/2021, Preferred Series A-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[41] |
250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[41] |
180,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Medical Devices & Equipment, Orchestra BioMed Holdings, Inc., Equity, 8/4/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
1,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
2,262,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Medical Devices & Equipment, Total Coronado Aesthetics, LLC |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
250,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
180,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Semiconductors, Achronix Semiconductor Corporation, Equity, 6/26/2015, Preferred Series D-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
7,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
181,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Semiconductors, Achronix Semiconductor Corporation, Equity, 7/1/2011, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
160,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
59,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Semiconductors, Total Achronix Semiconductor Corporation |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
167,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
240,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Planet Labs PBC, Equity, 1/13/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[54] |
1,527,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[54] |
992,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Stoke Space Technologies, Inc., Equity, 2/6/2026, Preferred Series D-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,407,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
2,511,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Stoke Space Technologies, Inc., Equity, 8/19/2026, Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,406,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
1,365,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Stoke Space Technologies, Inc., Equity, 9/23/2025, Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,406,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
3,684,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Space Technologies, Total Stoke Space Technologies, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
4,219,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
7,560,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Sustainable and Renewable Technology, Impossible Foods, Inc., Equity, 5/10/2019, Preferred Series E-1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
2,000,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
89,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Sustainable and Renewable Technology, Modumetal, Inc., Equity, 6/1/2015, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Sustainable and Renewable Technology, Pivot Bio, Inc., Equity, 6/28/2021, Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
4,500,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
377,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, Sustainable and Renewable Technology, SUNation Energy, Inc., Equity, 12/10/2020, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
3,153,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, System Software, Docker, Inc., Equity, 11/29/2018, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
4,284,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
150,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity Investments, System Software, Lightbend, Inc., Equity, 12/4/2020, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
265,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Equity, Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
632,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
162,000
|
|
|
| Investment, Identifier [Axis]: Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
10,250,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
10,250,000
|
|
|
| Investment, Identifier [Axis]: Investment Fund, Cash & Cash Equivalents, GS Financial Square Government Fund, FGTXX/38141W273 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
68,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
68,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Cybersecurity and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[9],[10],[17] |
|
|
|
|
385,000
|
|
|
| Investments, at fair value: |
[4],[9],[10],[17] |
|
|
|
|
364,000
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[11],[17] |
|
|
|
|
2,906,000
|
|
|
| Investments, at fair value: |
[4],[11],[17] |
|
|
|
|
5,408,000
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[11],[17] |
|
|
|
|
1,349,000
|
|
|
| Investments, at fair value: |
[4],[11],[17] |
|
|
|
|
1,291,000
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments, Cybersecurity, Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, 7/21/2022 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[42] |
385,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[42] |
365,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments, Drug Discovery & Development, Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, 11/16/2020 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[35],[36] |
3,070,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[35],[36] |
4,781,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments, Drug Discovery & Development, Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, 6/23/2022 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[35],[36] |
1,716,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[35],[36] |
1,497,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments, Drug Discovery & Development, Forbion Ventures Fund VIII Coöperatief U.A., Investment Funds & Vehicles, 7/23/2026 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[25],[35],[36] |
158,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[25],[35],[36] |
159,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Annex Cloud, Warrant, Acquisition Date 6/5/2025, Series Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
0
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
448,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
207,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
215,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
81,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Carbyne, Inc., Warrant, Acquisition Date 2/24/2025, Series Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
24,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
460,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[10],[17] |
|
|
|
|
26,000
|
|
|
| Investments, at fair value: |
[4],[10],[17] |
|
|
|
|
75,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
461,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
864,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
545,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
41,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Distributed Creation Inc., Warrant, Acquisition Date 4/21/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
180,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
248,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
278,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
440,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Earnix, Inc., Warrant, Acquisition Date 6/6/2024, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
220,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
283,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
96,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
1,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
325,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
110,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Funnel Holding AB (publ), Warrant, Acquisition Date 10/24/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[10],[17] |
|
|
|
|
46,000
|
|
|
| Investments, at fair value: |
[4],[10],[17] |
|
|
|
|
47,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
208,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
104,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[8],[10],[17] |
|
|
|
|
39,000
|
|
|
| Investments, at fair value: |
[4],[8],[10],[17] |
|
|
|
|
33,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Mango Technologies, Inc., Warrant, Acquisition Date 8/15/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
401,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
410,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
252,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
331,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Pindrop Security, Inc., Warrant, Acquisition Date 6/26/2024, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[10] |
|
|
|
|
494,000
|
|
|
| Investments, at fair value: |
[3],[10] |
|
|
|
|
320,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
215,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
609,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[8],[10] |
|
|
|
|
96,000
|
|
|
| Investments, at fair value: |
[8],[10] |
|
|
|
|
7,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Sisense Ltd., Warrant, Acquisition Date 6/8/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[10],[17] |
|
|
|
|
174,000
|
|
|
| Investments, at fair value: |
[4],[10],[17] |
|
|
|
|
44,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Suzy, Inc., Warrant, Acquisition Date 8/24/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[5],[10] |
|
|
|
|
367,000
|
|
|
| Investments, at fair value: |
[3],[5],[10] |
|
|
|
|
182,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[10],[19] |
|
|
|
|
360,000
|
|
|
| Investments, at fair value: |
[4],[10],[19] |
|
|
|
|
255,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/27/2025, Series Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10],[19] |
|
|
|
|
136,000
|
|
|
| Investments, at fair value: |
[10],[19] |
|
|
|
|
83,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Total Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
496,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
338,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Ushur, Inc., Warrant, Acquisition Date 6/5/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[5],[10] |
|
|
|
|
265,000
|
|
|
| Investments, at fair value: |
[3],[5],[10] |
|
|
|
|
183,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[8],[9] |
|
|
|
|
126,000
|
|
|
| Investments, at fair value: |
[8],[9] |
|
|
|
|
4,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
1,275,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
2,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Application Software and ZeroEyes, Inc., Warrant, Acquisition Date 5/6/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[5],[10] |
|
|
|
|
132,000
|
|
|
| Investments, at fair value: |
[3],[5],[10] |
|
|
|
|
34,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
36,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
31,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Antheia, Inc., Warrant, Acquisition Date 8/29/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
1,601,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
2,547,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[8] |
|
|
|
|
461,000
|
|
|
| Investments, at fair value: |
[8] |
|
|
|
|
62,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[8] |
|
|
|
|
242,000
|
|
|
| Investments, at fair value: |
[8] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
228,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
17,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
713,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Altumint, Inc., Warrant, Acquisition Date 10/31/2024, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
126,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
155,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and AppDirect, Inc., Warrant, Acquisition Date 9/22/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
228,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
188,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17] |
|
|
|
|
164,000
|
|
|
| Investments, at fair value: |
[4],[17] |
|
|
|
|
232,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 2/13/2024, Series Preferred Series D-4 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17] |
|
|
|
|
20,000
|
|
|
| Investments, at fair value: |
[4],[17] |
|
|
|
|
62,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
20,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
116,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
11,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
39,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
7,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Peek Travel, Inc., Warrant, Acquisition Date 10/28/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
157,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
163,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17] |
|
|
|
|
60,000
|
|
|
| Investments, at fair value: |
[4],[17] |
|
|
|
|
24,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi., Warrant, Acquisition Date 12/22/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
166,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
12,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
470,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[8],[19] |
|
|
|
|
1,242,000
|
|
|
| Investments, at fair value: |
[8],[19] |
|
|
|
|
5,096,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
57,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
2,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
83,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
16,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
782,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
62,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
985,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
1,214,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Carwow LTD |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
184,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
294,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Skyword, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
140,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
2,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
860,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Akeyless Security Ltd. and Warrant, Acquisition Date 8/4/2025 and Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[9],[10],[17] |
|
|
|
|
68,000
|
|
|
| Investments, at fair value: |
[4],[9],[10],[17] |
|
|
|
|
47,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
284,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
401,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Coronet Cyber Security Ltd. and Warrant, Acquisition Date 9/26/2024 and Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
254,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
25,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Dragos, Inc. and Warrant, Acquisition Date 6/28/2023 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
1,575,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
970,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Morphisec Information Security 2014 Ltd. and Warrant, Acquisition Date 10/1/2024 and Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[9],[10],[17] |
|
|
|
|
104,000
|
|
|
| Investments, at fair value: |
[4],[9],[10],[17] |
|
|
|
|
58,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Cybersecurity and Semperis Technologies Inc. and Warrant, Acquisition Date 4/23/2024 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
446,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
455,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Defense Technologies and Saronic Technologies, Inc., Warrant, Acquisition Date 6/9/2025, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[5] |
|
|
|
|
726,000
|
|
|
| Investments, at fair value: |
[3],[5] |
|
|
|
|
1,094,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[8],[49] |
|
|
|
|
1,290,000
|
|
|
| Investments, at fair value: |
[4],[8],[49] |
|
|
|
|
5,765,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Beren Therapeutics P.B.C., Warrant, Acquisition Date 10/8/2025, Series Preferred Series A+ |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
102,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
117,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17],[49] |
|
|
|
|
278,000
|
|
|
| Investments, at fair value: |
[4],[17],[49] |
|
|
|
|
127,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
287,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
65,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
37,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cuervo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
233,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
272,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[49] |
|
|
|
|
228,000
|
|
|
| Investments, at fair value: |
[3],[49] |
|
|
|
|
67,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[4],[49] |
|
|
|
|
88,000
|
|
|
| Investments, at fair value: |
[3],[4],[49] |
|
|
|
|
16,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[49] |
|
|
|
|
570,000
|
|
|
| Investments, at fair value: |
[4],[49] |
|
|
|
|
4,669,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[4],[8],[19],[49] |
|
|
|
|
848,000
|
|
|
| Investments, at fair value: |
[3],[4],[8],[19],[49] |
|
|
|
|
180,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
20,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
10,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
296,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and SynOx Therapeutics Limited, Warrant, Acquisition Date 4/18/2024, Series Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17] |
|
|
|
|
83,000
|
|
|
| Investments, at fair value: |
[4],[17] |
|
|
|
|
84,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 12/30/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[49] |
|
|
|
|
721,000
|
|
|
| Investments, at fair value: |
[4],[49] |
|
|
|
|
1,311,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
256,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
61,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
510,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
8,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17],[49] |
|
|
|
|
118,000
|
|
|
| Investments, at fair value: |
[4],[17],[49] |
|
|
|
|
170,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
101,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
30,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
34,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
61,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
557,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
386,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Energy Technologies and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9] |
|
|
|
|
52,000
|
|
|
| Investments, at fair value: |
[9] |
|
|
|
|
45,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Energy Technologies and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[9] |
|
|
|
|
507,000
|
|
|
| Investments, at fair value: |
[3],[9] |
|
|
|
|
100,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[9],[10],[17] |
|
|
|
|
54,000
|
|
|
| Investments, at fair value: |
[4],[9],[10],[17] |
|
|
|
|
811,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Finix Payment, Inc., Warrant, Acquisition Date 12/17/2025, Series Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[5],[9] |
|
|
|
|
38,000
|
|
|
| Investments, at fair value: |
[5],[9] |
|
|
|
|
38,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Total Worldremit Group Limited |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9] |
|
|
|
|
155,000
|
|
|
| Investments, at fair value: |
[9] |
|
|
|
|
55,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[9],[17] |
|
|
|
|
129,000
|
|
|
| Investments, at fair value: |
[4],[9],[17] |
|
|
|
|
55,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Financial Technologies and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[9],[17] |
|
|
|
|
26,000
|
|
|
| Investments, at fair value: |
[4],[9],[17] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Belong Health, Inc., Warrant, Acquisition Date 11/13/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[5] |
|
|
|
|
400,000
|
|
|
| Investments, at fair value: |
[5] |
|
|
|
|
238,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC, Warrant, Acquisition Date 1/4/2024, Series Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
156,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
718,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Octave Health Group, Inc., Warrant, Acquisition Date 11/28/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[5] |
|
|
|
|
168,000
|
|
|
| Investments, at fair value: |
[5] |
|
|
|
|
175,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc., Warrant, Acquisition Date 7/3/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
382,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
50,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC, Warrant, Acquisition Date 9/28/2023, Series Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3] |
|
|
|
|
278,000
|
|
|
| Investments, at fair value: |
[3] |
|
|
|
|
501,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Technology & Digital Health and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9],[10] |
|
|
|
|
739,000
|
|
|
| Investments, at fair value: |
[9],[10] |
|
|
|
|
220,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Technology & Digital Health and Imagen Technologies, Inc., Warrant, Acquisition Date 11/26/2025, Series Preferred Series C-3-VI |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[5],[9],[10] |
|
|
|
|
110,000
|
|
|
| Investments, at fair value: |
[5],[9],[10] |
|
|
|
|
92,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Technology & Digital Health and Modern Life, Inc, Warrant, Acquisition Date 3/30/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9] |
|
|
|
|
229,000
|
|
|
| Investments, at fair value: |
[9] |
|
|
|
|
70,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Technology & Digital Health and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[9] |
|
|
|
|
121,000
|
|
|
| Investments, at fair value: |
[9] |
|
|
|
|
48,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Quid, Inc., Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
356,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[17] |
|
|
|
|
57,000
|
|
|
| Investments, at fair value: |
[4],[17] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
537,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
185,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
528,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and VulcanForms Inc., Warrant, Acquisition Date 1/30/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
37,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
64,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
67,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
32,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Orchestra BioMed Holdings, Inc., Warrant, Acquisition Date 11/6/2024, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[5],[49] |
|
|
|
|
216,000
|
|
|
| Investments, at fair value: |
[3],[5],[49] |
|
|
|
|
299,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc, Warrant, Acquisition Date 9/8/2023, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
276,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
75,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Sight Sciences, Inc., Warrant, Acquisition Date 1/22/2024, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[5],[8],[49] |
|
|
|
|
363,000
|
|
|
| Investments, at fair value: |
[5],[8],[49] |
|
|
|
|
385,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[49] |
|
|
|
|
61,000
|
|
|
| Investments, at fair value: |
[49] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 1/11/2017, Series Preferred Series D-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
92,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
49,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Space Technologies and HawkEye 360, Inc. and Warrant and 12/18/2025 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
263,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
283,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Space Technologies and Loft Orbital Solutions Inc. and Warrant and 9/10/2025 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2] |
|
|
|
|
185,000
|
|
|
| Investments, at fair value: |
|
|
|
|
|
184,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Space Technologies and Stoke Space Technologies, Inc., Warrant, Acquisition Date 6/16/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[3],[5] |
|
|
|
|
990,000
|
|
|
| Investments, at fair value: |
[3],[5] |
|
|
|
|
2,301,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Tidal Vision Products, Inc., Warrant, Acquisition Date 10/10/2025, Series Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[5] |
|
|
|
|
232,000
|
|
|
| Investments, at fair value: |
[5] |
|
|
|
|
174,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and CloudBolt Software, Inc. and Warrant, Acquisition Date 9/30/2020 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
117,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
1,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and Cloudian, Inc. and Warrant, Acquisition Date 11/6/2018 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
71,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
0
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and Harness, Inc. and Warrant, Acquisition Date 3/12/2024 and Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
534,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
1,446,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and Lightbend, Inc. and Warrant, Acquisition Date 2/14/2018 and Preferred Series LB-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[10] |
|
|
|
|
131,000
|
|
|
| Investments, at fair value: |
[10] |
|
|
|
|
38,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments and System Software and Scylla DB Ltd. and Warrant, Acquisition Date 7/24/2025 and Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[2],[4],[10],[17] |
|
|
|
|
52,000
|
|
|
| Investments, at fair value: |
[4],[10],[17] |
|
|
|
|
$ 59,000
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Annex Cloud, Warrant, 6/5/2025, Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[30] |
0
|
|
|
|
|
|
|
| Investments, at fair value: |
[30] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Automation Anywhere, Inc., Warrant, 9/23/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
448,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
144,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Brain Corporation, Warrant, 10/4/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
215,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
67,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Cutover, Inc., Warrant, 9/21/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
26,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
35,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Dashlane, Inc., Warrant, 3/11/2019, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
461,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
810,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Demandbase, Inc., Warrant, 8/2/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
545,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
19,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, DevRev, Inc., Warrant, 6/8/2026, Preferred Series A |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
47,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
78,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Distributed Creation Inc., Warrant, 4/21/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
180,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
242,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Earnix, Inc., Warrant, 6/6/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
220,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
334,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, First Insight, Inc., Warrant, 5/10/2018, Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
96,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Fulfil Solutions, Inc., Warrant, 7/29/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
325,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
94,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Funnel Holding AB (publ), Warrant, 10/24/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
51,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
47,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Kore.ai, Inc., Warrant, 3/31/2023, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
208,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
46,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Leapwork ApS, Warrant, 1/23/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
39,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
12,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Mango Technologies, Inc., Warrant, 8/15/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[37] |
377,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[37] |
284,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Mixpanel, Inc., Warrant, 9/30/2020, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
252,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
250,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Pindrop Security, Inc., Warrant, 6/26/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
494,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
370,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Sisense Ltd., Warrant, 6/8/2023, Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
174,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
2,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Suzy, Inc., Warrant, 8/24/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38] |
367,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Tipalti Solutions Ltd., Warrant, 3/22/2023, Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[39] |
360,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[39] |
187,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Tipalti Solutions Ltd., Warrant, 3/27/2025, Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[39] |
136,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[39] |
35,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Total Tipalti Solutions Ltd. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
496,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
222,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Ushur, Inc., Warrant, 6/5/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38] |
265,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38] |
71,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, Veem, Inc., Warrant, 3/31/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
126,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
2,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, VideoAmp, Inc., Warrant, 1/21/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
1,275,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, ZeroEyes, Inc., Warrant, 5/6/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38] |
140,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38] |
29,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Application Software, micro1 Inc., Warrant, 5/20/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
369,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
441,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Biotechnology Tools, Alamar Biosciences, Inc., Warrant, 6/21/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
36,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
637,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Biotechnology Tools, Antheia, Inc., Warrant, 8/29/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
1,601,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
3,402,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Communications & Networking, Aryaka Networks, Inc., Warrant, 6/28/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[37] |
242,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[37] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Communications & Networking, Tarana Wireless, Inc.., Warrant, 3/20/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
43,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
19,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Products, Gadget Guard, LLC, Warrant, 6/3/2014, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
228,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Products, Whoop, Inc., Warrant, 6/27/2018, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
17,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
2,024,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Altumint, Inc., Warrant, 10/31/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
127,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
24,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, AppDirect, Inc., Warrant, 9/22/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
254,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
82,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Carwow LTD, Warrant, 12/14/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
164,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
134,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Carwow LTD, Warrant, 2/13/2024, Preferred Series D-4 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
20,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
34,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Houzz, Inc., Warrant, 10/29/2019, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
20,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Landing Holdings Inc., Warrant, 3/12/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
116,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
1,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Lendio, Inc., Warrant, 3/29/2019, Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
39,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Peek Travel, Inc., Warrant, 10/28/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
157,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
79,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Perk Group Inc., Warrant, 5/13/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
207,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
207,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Plentific Ltd, Warrant, 10/3/2023, Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
60,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
35,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Provi, Warrant, 12/22/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
166,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
3,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Rhino Labs, Inc., Warrant, 3/12/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
470,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, SeatGeek, Inc., Warrant, 6/12/2019, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[37] |
1,242,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[37] |
5,505,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Skyword, Inc., Warrant, 11/14/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
57,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
5,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Skyword, Inc., Warrant, 8/23/2019, Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
83,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Snagajob.com, Inc., Warrant, 4/20/2020, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
16,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Snagajob.com, Inc., Warrant, 8/1/2018, Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
62,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Thumbtack, Inc., Warrant, 5/1/2018, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
985,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
1,013,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Total Carwow LTD |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
184,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
168,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Total Skyword, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
140,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
5,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Consumer & Business Services, Total Snagajob.com, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
78,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Akeyless Security Ltd., Warrant, 8/4/2025, Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[42] |
103,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[42] |
80,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Bitsight Technologies, Inc., Warrant, 11/18/2020, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
284,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
470,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Coronet Cyber Security Ltd., Warrant, 9/26/2024, Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
254,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
3,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Morphisec Information Security 2014 Ltd., Warrant, 10/1/2024, Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[42] |
104,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[42] |
56,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Cybersecurity, Semperis Technologies Inc., Warrant, 4/23/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
446,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
985,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Allen Control Systems Inc., Warrant, 9/16/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
297,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
294,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Hermeus Corporation, Warrant, 3/20/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
577,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
920,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Saronic Technologies, Inc., Warrant, 6/15/2026, Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[39] |
1,283,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[39] |
763,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Saronic Technologies, Inc., Warrant, 6/9/2025, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38],[39] |
726,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38],[39] |
1,837,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Defense Technologies, Total Saronic Technologies, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
2,009,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
2,600,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Axsome Therapeutics, Inc., Warrant, 1/9/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[54] |
410,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[54] |
1,748,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Beren Therapeutics P.B.C., Warrant, 10/8/2025, Preferred Series A+ |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
246,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
323,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, COMPASS Pathways plc, Warrant, 6/30/2023, Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[54] |
278,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[54] |
348,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Cellarity, LLC (p.k.a. Cellarity, Inc.), Warrant, 12/8/2021, Preferred Series B Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
287,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
86,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Century Therapeutics, Inc., Warrant, 9/14/2020, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
37,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Heron Therapeutics, Inc., Warrant, 8/9/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[54] |
228,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[54] |
2,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Kura Oncology, Inc., Warrant, 11/2/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[35],[54] |
88,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[35],[54] |
19,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Lexicon Pharmaceuticals, Inc., Warrant, 5/4/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[37],[38],[54] |
447,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[37],[38],[54] |
529,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Madrigal Pharmaceuticals, Inc., Warrant, 5/9/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[54] |
570,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[54] |
3,906,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Phathom Pharmaceuticals, Inc., Warrant, 9/17/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[35],[39],[54] |
848,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[35],[39],[54] |
25,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Redshift Bioanalytics, Inc., Warrant, 3/23/2022, Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
20,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
20,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Rocket Pharmaceuticals, Inc., Warrant, 9/30/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[38],[54] |
412,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[38],[54] |
411,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Scynexis, Inc., Warrant, 5/14/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
296,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, SynOx Therapeutics Limited, Warrant, 4/18/2024, Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
199,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
160,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, Valo Health, LLC, Warrant, 6/15/2020, Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
256,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
87,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, X4 Pharmaceuticals, Inc., Warrant, 3/18/2019, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
510,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
2,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Drug Discovery & Development, enGene Therapeutics Inc. (p.k.a. enGene, Inc.), Warrant, 12/22/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[54] |
218,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[54] |
30,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Electronics & Computer Hardware, 908 Devices, Inc., Warrant, 3/15/2017, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
101,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
200,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Electronics & Computer Hardware, Locus Robotics Corp., Warrant, 6/21/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
34,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
76,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Electronics & Computer Hardware, Skydio, Inc., Warrant, 11/8/2021, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
557,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
651,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Energy Technologies, Ampion, PBC, Warrant, 4/15/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
52,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
1,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Energy Technologies, Antares Nuclear, Inc., Warrant, 9/3/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
486,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
441,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Energy Technologies, Electric Hydrogen Co., Warrant, 3/27/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[42] |
507,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[42] |
97,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Cloudpay, Inc., Warrant, 4/10/2018, Preferred Series B |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[42] |
54,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[42] |
706,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Finix Payments, Inc., Warrant, 12/17/2025, Preferred Series C |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38],[42] |
122,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[42] |
171,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Total Worldremit Group Limited |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
155,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
12,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Worldremit Group Limited, Warrant, 2/11/2021, Preferred Series D |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[42] |
129,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[42] |
12,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Financial Technologies, Worldremit Group Limited, Warrant, 8/27/2021, Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36],[42] |
26,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36],[42] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Belong Health, Inc., Warrant, 11/13/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
400,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
141,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Connections Health Holdings, LLC, Warrant, 5/27/2026, Class B Preferred Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
94,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
133,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Curana Health Holdings, LLC, Warrant, 1/4/2024, Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
156,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
548,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Octave Health Group, Inc. , Warrant, 11/28/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
168,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
176,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, Strive Health Holdings, LLC, Warrant, 9/28/2023, Common Units |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32] |
278,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32] |
738,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Services, Other, The Recovery Company, Inc. (p.k.a. Recover Together, Inc.), Warrant, 7/3/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
382,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
18,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, CollectiveHealth, Inc., Warrant, 1/26/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
21,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
12,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, Elation Health, Inc., Warrant, 9/12/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
739,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
187,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, Imagen Technologies, Inc., Warrant, 11/26/2025, Preferred Series C-3-VI |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38],[42] |
110,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38],[42] |
380,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, Modern Life, Inc., Warrant, 3/30/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
229,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
138,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Healthcare Technology & Digital Health, Vida Health, Inc., Warrant, 3/28/2022, Preferred Series E |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[42] |
120,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[42] |
110,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Information Services, NetBase Quid, Inc., Warrant, 8/22/2017, Preferred Series 1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
356,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Manufacturing Technology, Bright Machines, Inc., Warrant, 3/31/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
537,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
258,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Manufacturing Technology, MacroFab, Inc., Warrant, 3/23/2022, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
528,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Manufacturing Technology, VulcanForms Inc., Warrant, 1/30/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
74,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
340,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Media/Content/Info, Fever Labs, Inc., Warrant, 12/30/2022, Preferred Series E-1 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
67,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
44,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Cognito Therapeutics Group, Inc., Warrant, 1/23/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
149,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
177,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Orchestra BioMed Holdings, Inc., Warrant, 11/6/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38],[54] |
216,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38],[54] |
470,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Senseonics Holdings, Inc., Warrant, 5/6/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[37],[54] |
110,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[37],[54] |
287,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Senseonics Holdings, Inc., Warrant, 9/8/2023, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[37],[54] |
277,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[37],[54] |
168,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Sight Sciences, Inc., Warrant, 1/22/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[37],[38],[54] |
363,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[37],[38],[54] |
468,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Tela Bio, Inc., Warrant, 3/31/2017, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
61,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Medical Devices & Equipment, Total Senseonics Holdings, Inc. |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
387,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
455,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Semiconductors, Achronix Semiconductor Corporation, Warrant, 1/11/2017, Preferred Series D-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
92,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
89,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Space Technologies, HawkEye 360, Inc., Warrant, 12/18/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[54] |
227,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[54] |
230,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Space Technologies, LeoLabs, Inc., Warrant, 4/8/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
118,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
117,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Space Technologies, Loft Orbital Solutions Inc.., Warrant, 9/10/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
185,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
208,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Space Technologies, Stoke Space Technologies, Inc., Warrant, 6/16/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[32],[38] |
990,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[32],[38] |
7,372,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, Sustainable and Renewable Technology, Tidal Vision Products, Inc., Warrant, 10/10/2025, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[38] |
304,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[38] |
202,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, CloudBolt Software, Inc., Warrant, 9/30/2020, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
117,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Cloudian, Inc., Warrant, 11/6/2018, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
71,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, ControlUp Technologies Ltd., Warrant, 1/2/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
33,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
40,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Harness, Inc., Warrant, 3/12/2024, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
534,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
856,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Lightbend, Inc., Warrant, 2/14/2018, Preferred Series LB-2 |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
131,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
0
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Neo4j, Inc., Warrant, 3/31/2026, Common Stock |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1] |
42,000
|
|
|
|
|
|
|
| Investments, at fair value: |
|
87,000
|
|
|
|
|
|
|
| Investment, Identifier [Axis]: Warrant Investments, System Software, Scylla DB Ltd., Warrant, 7/24/2025, Ordinary Shares |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
[1],[35],[36] |
52,000
|
|
|
|
|
|
|
| Investments, at fair value: |
[35],[36] |
$ 34,000
|
|
|
|
|
|
|
| 1-month SOFR |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Interest rate |
|
3.91%
|
|
3.91%
|
3.91%
|
3.69%
|
3.69%
|
3.69%
|
| 3-month SOFR |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Interest rate |
|
4.08%
|
|
4.08%
|
4.08%
|
3.65%
|
3.65%
|
3.65%
|
| 6-month SOFR |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Interest rate |
|
4.27%
|
|
4.27%
|
4.27%
|
3.57%
|
3.57%
|
3.57%
|
| Common Stock | Significant Other Observable Inputs (Level 2) |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Number of publicly traded companies | firm |
|
28
|
|
28
|
28
|
26
|
26
|
26
|
| Warrants | Quoted Prices in Active Markets for Identical Assets (Level 1) |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Number of publicly traded companies | firm |
|
19
|
|
19
|
19
|
16
|
16
|
16
|
| Black Crow AI, Inc. affiliates | Promissory Note |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Principal amount |
|
$ 3,100,000
|
|
|
|
$ 2,800,000
|
|
|
| Phathom Pharmaceuticals Inc [Member] | Royalty Contract |
|
|
|
|
|
|
|
|
| Investment Holding [Line Items] |
|
|
|
|
|
|
|
|
| Investment cost |
|
11,200,000
|
|
|
|
11,600,000
|
|
|
| Investments, at fair value: |
|
$ 12,700,000
|
|
|
|
$ 11,900,000
|
|
|
|
|